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ABSTRACT

CHANGES IN GABAA RECEPTOR EXPRESSION AND ALTERATIONS IN
Ca++/CALMODULIN-DEPENDENT PROTEIN KINASE II ACTIVITY IN A
HIPPOCAMP AL NEURONAL CULTURE MODEL OF EPILEPSY
By Robert Eagan Blair, B.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 1998
Major Director:

Dr. Robert J. DeLorenzo, M.D., Ph.D., M.P.H.
Chairman, Department of Neurology

Expression levels of GABAA receptor subunits and activity of the Ca++/calmodulindependent protein kinase II (CaM kinase II) enzyme system were evaluated in an in vitro
hippocampal neuronal culture model of epilepsy. Treatment of hippocampal neuronal
cultures with Mg++-free media for 3 hours results in the induction of an enduring "epileptic"
state as evidenced by the expression of spontaneous recurrent seizure (SRS) discharge. The
induction of the SRS activity was shown to be a N-methyl-D-aspartate (NMDA) receptor,
ca••-dependent mechanism (Sombati and DeLorenzo, J Neurophys., 73 (4), 1995).
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Significant and long-lasting decreases in mRNA expression for the GABAA a:2 and a:5
receptor subunits were observed in association with the induction of SRSs in this model,
while levels for al, p2 and y2 subunits showed no significant change. Irreversible (3H]
flunitrazepam saturation binding analysis in membrane preparations demonstrated a
significant decrease in specific binding in association with the SRS activity observed in this
model. No changes in GABAA P subunit immunoreactivity were detected. Selective
suppression ofthe GABAA a:2 subunit protein levels in hippocampal neuronal cultures using
antisense oligonucleotide technology caused a significant decrease in the amplitude of
spontaneous inhibitory postsynaptic currents (sIPSC).
CaM kinase II is highly enriched in the brain and mediates many processes essential
to neuronal function and viability. Induction of SRSs in hippocampal cultures were
associated with a long-lasting and significant decrease in activity ofCaM kinase II. Addition
of2-amino-5-phosphovaleric acid to the low Mg+• treatment solution prevented the decrease
in CaM kinase II activity. Suppression ofCaM kinase II activity in hippocampal cultures by
treatment with either an antisense oligonucleotide specific for a CaM kinase II or KN93
(selective CaM kinase II inhibitor) resulted in significant reductions in IPSC amplitude. This
data suggests that CaM kinase II can act to regulate GABAergic inhibitory function in
hippocampal cultures. The findings of this study demonstrate long-lasting decreases in
GABAA receptor expression and activity of CaM kinase II, which may contribute to the
induction of the "epileptic" state of this model.

GENERAL INTRODUCTION
A.

Seizures and Epilepsy:

A seizure can be defined as the synchronous and uncontrollable firing of a population
of neurons (Lothman et al., 1991). Seizure discharges are paroxysmal, they have a distinct
onset and termination. The occurrence of seizure activity does not necessarily indicate a
permanent alteration in neuronal function, but rather an isolated episode that can be
precipitated by a variety of insults to the brain. These include trauma, toxins, drug
withdrawal and metabolic disturbances. A classification of seizures has been developed that
incorporates data from clinical evaluations and animal models (Lothman et al., 1991).
Partial seizures involve specific brain foci and express themselves by a variety of behavioral
and motor manifestations. This class of seizures is subdivided into simple and complex, the
latter involving loss of consciousness. Partial seizures have the ability to propagate
throughout the brain and become generalized. Generalized seizures involve large areas of
the brain and are bilateral in nature. Behavioral manifestations that ensue with generalized
seizures range from loss of consciousness to major motor convulsions (tonic-clonic, clonic,
or tonic). It has been estimated that approximately 10% of the population will experience
a seizure at some time during their life (Lothman et al., 1991 ).
Epilepsy is a condition that displays recurrent seizures over time and affects
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approximately 1% of the population (Hauser and Hesdorffer, 1990). Unlike a single seizure,
epilepsy is associated with spontaneous recurrent seizures (SRS) and is the result of a long
lasting alteration in neuronal function at the cellular level. Although there are a wide variety
of pharmacological interventions which allow for the successful management of epilepsy,
the mechanisms that underlie this condition are still unclear.
B.

Mechanisms of Epileptogenesis:

Epileptogenesis has been attributed to alterations in both excitatory and inhibitory
synaptic function.

Although changes in these two systems, either independently or in

concert with each other, play an important role in seizure induction at the functional level,
the multitude of underlying regulatory pathways involved in sustaining the epileptogenic
phenotype is very complex. Many investigations employing both in vitro and in vivo models
of seizures and epilepsy have shed light on some of these underlying mechanisms.
In many seizure models, a significant and well documented phenomenon is the
observation of selective cell loss in the hippocampus, accompanied by sprouting of mossy
fibers onto targets that did not receive those inputs previously (Parent et al., 1997). This is
also seen in brain tissue taken from temporal lobe epilepsy (TLE) patients (Sutula, 1990).
This "re-wiring" of neuronal circuitry has been shown to predominantly occur in the hilar
cells of the dentate gyros (DG), a region usually resistant to seizure induction (Parent et al.,
1997). This neurogenesis and aberrant synaptic reorganization leads to an increased number
of excitatory synapses, culminating in the induction of a hyperexcitable state.

The

potentiation of neuronal excitability is thought to contribute to the pathophysiological
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manifestations evident in these models (Parent et al., 1997; Sutula, 1990).
Enhancement of excitatory synaptic transmission in association with the induction
and maintenance of neuronal hyperexcitability observed with epileptogenesis has been
another area of intense study. An increase in the function of the N-methyl-D-aspartate
(NMDA) receptor in the kindling model of epilepsy has been demonstrated (Martin et al.,
1992; Kohr et al., 1993). Induction of both the kindling model of epilepsy (Sutula et al.,
1996) and continuous hippocampal stimulation model of status epilepticus (Young and
Dragunow, 1994) are dependent on NMDA receptor activation. Stringer and Lothrnan
(1992) have observed a phenomenon they termed "maximal dentate activation" (MDA) in
models that displayed seizure afterdischarges. They proposed that the DG acts as a driving
force for the generation of seizure afterdischarges in the hippocampus and other brain regions
in the kindling model of epilepsy. Furthermore, it has been demonstrated that MDA is
dependent on NMDA receptor activation. Addition of MK-801 blocked MDA and
subsequent afterdischarge generation. In a model of self-sustaining limbic status epilepticus
(SSLSE) induced by continuous hippocampal stimulation, electrophysiological studies of
hippocampal slices from animals one month following stimulation, revealed an increase in
duration of EPSPs compared to controls. Addition of APV (2-amino-5-phosphovaleric
acid) to the recording solution suppressed the enhancement of EPSPs, suggesting that
NMDA receptor activation is a contributing factor in the modification of the EPSPs
evidenced in this model (Lothman et al., 1995).
Loss of inhibitory function as a mechanism for epileptogenesis has been the focus of
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much research. Areas of investigation have ranged from loss of innervation of inhibitory
intemeurons to changes in function ofreceptor systems at the post-synaptic membrane. One
proposal for the decrease in inhibitory function is the "dormant basket cell hypothesis" which
concludes that a specific loss of excitatory afferent projections to these GABAergic
intemeurons in the dentate gyrus renders this inhibitory pathway inactive (Dudek and Spitz,
1997; Sloviter, 1991). However, a recent investigation has shown evidence for an NMDA
receptor-dependent suppression ofhippocampal inhibition in a model ofSE (Mazarati and
Wasterlain, 1997).
Many studies have focused on investigating alterations in inhibitory function at the
postsynaptic membrane. In an in vitro model ofkindling in the hippocampal slice, a decrease
in the long-term depression ofevoked inhibitory potentials suggested alterations in function
of GABAA and GABA8 receptors (Merlin and Wong, 1993) A decrease in paired-pulse
depression in both the kindling model of epilepsy (Kapur et al., 1989) and the continuous
hippocampal stimulation model ofstatus epilepticus (Kapur and Lothman, 1989) has been
demonstrated, suggesting that suppression ofGABAergic inhibitory function contributes to
the underlying mechanisms ofseizure propagation in these models.
Transduction pathways and second messenger systems play an essential role in
maintaining normal cellular physiology. How alterations in these pathways may contribute
to seizure generation is a major research question. Several studies have demonstrated an
increase in activity ofthe protein kinase C (PKC) enzyme in the kindling model of epilepsy
(Chen et al., 1992; Kohira et al., 1992). A decrease in the ca++/calmodulin-dependent
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protein kinase II (CaM kinase II) system was observed in the same model (Bronstein et al.,
1990; Goldenring et al., 1986). CaM kinase II activity is decreased in a bicuculline induced
model of status epilepticus (Bronstein et al., 1988) and in a continuous hippocampal
stimulation model of status epilepticus (SE) (Perlin et al., 1992).
Although immediate changes in cellular components occur during the induction phase
of seizures and epilepsy, evidence suggests that the long-lived alterations that underlie the
recurrence of seizure expression are the result of changes at the genetic level. Research has
been carried out to determine the existence of "epilepsy" genes associated with human
idiopathic epilepsies, but this task has been difficult in establishing an involvement of the
genetic linkage with the neuropathological condition (Berkovic and Scheffer, 1997).
Experimental models of seizures and epilepsy allow for thorough investigation of how
changes in gene expression contribute to the induction and maintenance of these conditions.
Induction of selected transcription factors such as c-FOS, c-JUN, KROX, and CREB (cAMP
response element binding protein) have been demonstrated in animal models of seizures and
epilepsy (Herdegen et al., 1993; Labiner et al., 1993). It is thought that the induction of these
immediate early genes acts to regulate changes in expression of long-term effector genes
which underlie the maladaptive phenotype of seizures and epilepsy. A number of studies
have looked at seizures associated changes in effector genes. These include the GABAA
receptor system (Kamphuis et al., 1995; Kokaia et al., 1994; Rice et al., 1996; Vick et al.,
1996), NMDA receptor system (Kraus et al., 1994; Kraus et al., 1996; Vezzani et al., 1995),
AMPAIKA (cx-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/kainic acid) receptor

6
expression (Khrestchatisky et al., 1995), ca++/calmodulin-dependent protein kinase II
(Bronstein et al., 1992), cytoskeletal proteins (Kamphuis et al., 1995), and neurotrophic
factors (Emfors et al., 1991).
The general consensus is that there is a loss of balance between the excitatory and
inhibitory drives that regulate neuronal synaptic transmission. Substantial evidence suggests
that alterations in GABAergic receptor function contribute towards the decrease in inhibitory
drive observed with epileptogenesis. The enhancement of selective excitatory receptor
systems have been shown to occur in seizure models. Potentiation of these pathways results
in the increased gating of ca++, a major second-messenger in the CNS (central nervous
system).

Changes in

intracellular Ca++ levels have been associated with both

neurophysiological and neuropathological processes (Ghosh and Greenberg, 1995; Chum,
1995). CaM kinase II is a multifunctional enzyme that is enriched in the brain. Alterations
in activity of this kinase have been associated with a number of pathological conditions
(Bronstein et al., 1988; Chum et al., 1992a; Churn et al., 1995; Chum et al., 1997;
Goldenring et al., 1986; Kochan et al., 1997; Perlin et al., 1992; Wasterlain and Farber, 1984;
Wasterlain et al., 1992).
We have chosen to investigate the function and expression of the GABAA receptor
channel in association with induction and maintenance of epileptogenesis. In addition, the
role of CaM kinase II in seizure and epilepsy will be investigated. To address these issues,
we will employ an in vitro hippocampal neuronal culture model of epilepsy.
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C.

In Vitro Model of Spontaneous Recurrent Seizure Activity in Primary
Hippocampal Cultured Neurons:

Treatment ofhippocampal cell cultures with a Mg++ -free media for three hours results
in the induction of an enduring "epileptic" state as evidenced by the expression of
spontaneous recurrent seizure discharge (Sombati and DeLorenzo, 1995). The seizures
exhibited in this model can be halted by classical anticonvulsant drugs. This blockade is
reversible, where upon removal of the agent results in resurgence of the seizure discharges.
This observation would suggest that a long-lived alteration is in place and underlies the
chronic expression of the pathophysiological condition exhibited in this model. Reducing
extracellular ca++ to 0.2 mM or applying 50 µM APV during the treatment protocol blocks
the induction of the "epileptic condition" in these cultures, suggesting an NMDA receptor,
Ca++-dependent mechanism of epileptogenesis associated with this paradigm. This model
allows easy evaluation and manipulation of the neuronal culture environment, creating a
powerful tool for the investigation of the biochemical, biophysical and genetic mechanisms
that underlie epilepsy and the seizures associated with it.
D.

Structure and Function of the GABAA Receptor Complex:

The y-aminobutyric acid type A (GABAJ receptor, a member ofthe ligand-gated ion
channel superfarnily, is the primary mediator offast inhibitory synaptic transmission in the
CNS (Barnard et al., 1987). Upon binding to the endogenous ligand GABA, the receptor
channel gates the influx of chloride resulting in hyperpolarization of the plasma membrane.
Activation of the GABAA receptor by selective agents regulates levels of vigilance, anxiety,
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muscle tension and epileptiform activity. The complexity of GABAA receptor regulation is
exhibited by a number of both positive and negative modulatory sites present on the receptor
channel which include those for GABA agonists/antagonists, benzodiazepines, barbiturates,
ethanol, neurosteroids, zinc, and picrotoxin (Barnard et al., 1987).
The GABAA receptor complex is a pentarneric structure composed of protein subunits
which surround the channel pore. To date, there have been at least thirteen different GABAA
receptor subunits isolated and cloned from the mammalian brain which include a 1.,;, p,_3, y1_3,
and o (McKeman and Whiting, 1996). Peptide analysis and hydropathy plots have
determined that each receptor subunit has four transmembrane spanning regions with the
second region lining the channel pore, a characteristic that is shared with other members of
the ligand-gated ion channel superfamily (Barnard et al., 1987). Each subunit has a large
NH2-terrninal extracellular domain which contains characteristics common to other receptor
proteins in this family such as N-linked glycosylation sites and Cys residues for the formation
of loops important in binding of GABA or other ligands to the receptor channel. On the
intracellular side, a large cytoplasmic loop between transmembrane regions 3 and 4 has been
shown to contain specific consensus sites for protein phosphorylation. This is a poorly
conserved region among the GABAA subunits, and is thought to engender selective
regulation of heterogeneous GABAA receptors by different kinase systems (Burt and
Karnatchi, 1991).
With the initial isolation and cloning of the a and P subunits of the GABAA receptor,
it was believed that a combination of these two receptor proteins could constitute a functional
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receptor complex (Barnard et al., 1987). Further studies determined that the addition ofthe
y subunit was necessary to confer benzodiazepine sensitivity to the GABAA complex, a
characteristic common to the native form ofthe receptor channel. Thus, it was determined
that the minimum requirement for the subunit make-up ofthe GABAA receptor was a.P.yx
(Pritchett et al., 1989). With the large number ofisolated and cloned receptor subunits and
the pharmacological diversity ofGABAA receptor responses observed throughout the CNS,
it was believed that changes in receptor subunit composition could underly the observed
heterogeneity of receptor response. Employment of recombinant receptor techniques and
expression systems in a number ofstudies have determined the contribution of different
GAB AA receptor subunits to the diversity ofchannel function.
Expression analysis ofhomomeric receptor channels resulted in little or no response
to applied GABA, suggesting that formation ofthe GABAA receptor from a single subunit
is highly unlikely (Sigel et al., 1990). It has been established that the presence of a P subunit
is required for GABA-dependent gating of the receptor channel and that co-expression of
both a and y subunits along with p significantly enhances GABA response. Substitution of
the y2 subunit with either y 1 or y3 in the a1 p2y, combination results in a receptor channel
with reduced affinity for benzodiazepine agonists (Luddens et al., 1995). Comparison
between different p subunit isoforms reveal that substitution of Pl with the

P2 subunit

increases the GABA-dependent gating ofthe receptor channel. These findings would suggest
that o:,

p, and y subunits can independently affect the efficacy of GABA-dependent gating

ofthe receptor channel (Sigel et al., 1990). With regards to benzodiazepine sensitivity of the
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GABAA receptor complex, expression studies have determined that a variation of expression
within the a subunit family controls the designation of either a high affinity (Type I) or low
affinity (Type Il) benzodiazepine/GABA receptor. Co-expression of the al subunit with the
p 1 y2 combination resulted in a receptor channel displaying characteristics of a high affinity
receptor channel. Substitution of the al with either a2, a3, or a5 resulted in a low affinity
receptor channel (Pritchett et al., 1989).
Even though the theoretical number of possible GABAA receptors formed from
different combinations of the known subunits exceeds 100,000, it is believed that fewer than
100 different arrangements of the receptor complex exist in the native form. Many studies
have been directed towards understanding the subunit makeup of GABAA receptors
throughout the nervous system.
Using data obtained from in situ hybridization analysis, immunohistochemistry,
immunopurification of native receptors and receptor binding studies, researchers have been
able to decipher the region specific variations in subunit composition of GABAA receptors.
Expression patterns for the al subunit are the most ubiquitous of the GABAA receptor
subunits and most always co-assemble with the p2 and y2 subunits.

Integrating

benzodiazepine binding analysis with regional expression patterns of the GABAA receptor
subunits indicates that the aI, p2, and y2 subunits co-localize throughout the brain and form
the high affinity BZ receptor; this subunit combination is believed to constitute up to 50%
of all GABAA receptors in the CNS (McKernan and Whiting, 1996). Regional distribution
of low affinity BZ receptor binding parallels expression patterns for the a2, a3 and aS
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receptor subunits. In the hippocampus, a2 and a5 are thought to co-assemble with !32/3 and
y2 subunits to make up the majority ofGABAA receptors in this region (Wisden et al., 1992).
Although the exact stoichiometry of native GABAA receptors is not yet known, integration
of the findings from recombinant receptor analysis, subunit expression patterns and binding
analysis will bring us closer to understanding which GABAA receptor subtypes actually exist
in the brain.
E.

Phosphorylation-dependent Regulation of GABAA Receptor Function:

One means of regulating GABAA receptor function is via post-translational
modification of the receptor subunit proteins in a phosphorylation-dependent manner. All
of the GABAA receptor subunits have been shown to contain at least one consensus site for
phosphorylation by selective kinases. These include Ca++-phospholipid-dependent kinase
(Moss et al., 1992a; Krishek et al., 1994), cAMP-dependent protein kinase (Moss et al.,
1992a; Feigenspan and Bormann, 1994), protein-tyrosine kinase (Valenzuela et al., 1995),
cGMP-dependent kinase and calcium/calmodulin-dependent protein kinase II (McDonald
and Moss, 1994). In a purified GABAA receptor preparation, it has been demonstrated that
phosphorylation occurs on serine, threonine and tyrosine residues in selective polypeptides
which co-migrated with [3H]-flunitrazepam labelled bands. Using a monoclonal antibody
specific for the GABAA a receptor proteins, it has been demonstrated that the phosphate
incorporation occurs on this subunit class of the receptor channel (Bureau and Laschet,
1995). Phosphorylation of GABAA receptor subunits can result in either enhancement or
suppression of the GABAergic inhibitory response.

Furthermore, different signal
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transduction pathways have been shown to incur opposite effects on GABAA receptor
function. In general, activation of both protein kinase A (Moss et al., 1992b)and protein
kinase C (Krishek et al., 1994) pathways result in attenuation of GABA-activated currents.
Contrary to these findings, Feigenspan and Bormann (1994) employing a retinal amacrine
cell preparation, demonstrated that activation of the protein kinase A pathway augmented
GABAergic inhibitory function. These discrepancies may be due to regional variations in
the subunit composition of the GABAA receptor observed throughout the CNS (Wisden et
al., 1992). Activation of tyrosine kinase ('1 alenzuela et al., 1995), cGMP-dependent kinase
(Leidenheimer, 1996), and Ca++/calmodulin-dependent protein kinase II (Kano et al., 1996;
Wang et al., 1995) pathways results in increased GABAA receptor function. These findings
demonstrate the complexity involved in post-translational regulation of the GABAA receptor
channel.
Modulation of GABAA receptor function also occurs via activation of selective
phosphatase pathways. Chen and Wong (1994) have shown that intracellular perfusion of
an active form of calcineurin (calcium-dependent phosphatase) into acutely isolated
hippocarnpal neurons, resulted in the depression of GABAA responses. They showed that
NMDA-dependent calcium influx suppressed the GABAA response. Tbis suppression could
be blocked by addition of okadaic acid (phosphatase inhibitor) or by replacement of
intracellular ATP with ATP-y-S (non-hydrolyzable form of ATP). Stelzer and Shi (1994)
demonstrated similar findings, indicating an NMDA receptor, Ca++-dependent mechanism
in reduction of GABAA responses. In addition, influx of Ca++ via activation of VSCCs did
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not result in a decrease in GABAA response. These results suggest that calcineurin decreases
GABAA receptor function in an NMDA/Ca++-dependent manner.
F.

Alterations in GABAergic Inhibitory Function in models of Seizure and
Epilepsy:

Although it is generally accepted that a decrease in inhibitory drive occurs in models
of seizure and epilepsy, a more thorough investigation of the alterations in inhibitory
processes is needed to understand the molecular mechanisms underlying these conditions.
Using the in vitro hippocampal neuronal culture model of spontaneous recurrent seizures
(Sombati and DeLorenzo, 1995), Gibbs et al. (1997b) demonstrated a seizure associated
decrease in GABAA receptor function.

Both GABA response and affinity for the

benzodiazepine clonazepam were suppressed in this model. In the rat pilocarpine model of
temporal lobe epilepsy, the same group evaluated GABAA receptor function in acutely
isolated CA 1 and dentate granule hippocampal neurons from control and seizure rats. They
found an enhancement and a suppression of receptor response in dentate gyrus and CA 1
regions respectively (Gibbs et al., 1997a). These findings support earlier work by Kamphuis
et al. (1992) using paired-pulse depression analysis of inhibitory function from kindled rat
hippocampal neurons. This study demonstrated both attenuation and augmentation of
GABAA receptor function in CAI and dentate granule cells respectively.
Using the continuous hippocampal stimulation model of status epilepticus, Kapur and
Lothman (1989) found a decrease in paired-pulse depression and showed that the loss of
GABAergic inhibition could be directly correlated with the severity of spontaneous seizures
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exhibited by each animal. Changes in properties of several of the allosteric modulatory sites
present on the GABAA receptor complex have been shown to occur in models of seizure and
epilepsy. These include a decrease in benzodiazepine sensitivity (Kapur and Macdonald,
1997), a decrease in [3H]-muscimol binding (Rice et al., 1996; Kapur et al., 1994) and
changes in zinc sensitivity (Buhl et al., 1996; Kapur and Macdonald, 1997). Investigations
are warranted to determine the molecular mechanisms that underlie the maladaptive state of
GABAA receptors in these pathophysiological conditions.
G.

Alterations in GABAA Receptor Subunit Expression in Models of Seizure and
Epilepsy:

A direction currently being taken to elucidate the underlying mechanisms ofseizures
and epilepsy is the study of how alterations in the level ofrnRNA expression for selective
GABAA receptor subunits is involved in these conditions. Rice et al. (1996) employed a rat
pilocarpine model of temporal lobe epilepsy and demonstrated a long-lasting decrease in
mRNA levels for the a2 and a5 GABAA receptor subunits in hippocampal CA1-CA3
regions. No changes in expression levels for the a 1, �2, or y2 subunits were observed. In
agreement with these findings, in situ hybridization analysis revealed a decrease in GABAA
a2 mRNA expression in an in vitro hippocampal slice model oflow-Mg++ induced stimulus
evoked seizures (Vick et al., 1996).
In the kainic acid model oftemporal lobe epilepsy, a decrease in GABAA al mRNA
expression in the CA3/CA4 region of the hippocampal formation has been observed and
precedes the neurodegeneration seen in this model (Friedman et al., 1994). Analysis of
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GABA A P i.; subunit expression levels in the hippocampus of electrically kindled rats was
carried out by Kamphuis et al. (1994). Region-specific changes in mRNA levels within the
hippocampal formation were detected and reflected by small and opposing changes of pI and
p2 (increase and decrease respectively) in CAI and CA3 neurons, while in fascia dentata
region a robust increase in P3 levels was evident. Additional work from the same group
involved a more extensive investigation of GABAA receptor subunit expression in the same
model at different stages of the kindling process; acquisition, 24 h after the last seizure and
28 days following completion of the kindling paradigm. During the acquisition phase of
kindling, they found that most of the subunits (al, a2, and a4, P 1•3, and y2S/2L)
demonstrated an increase in expression in both CA and DG regions of the hippocampus.
One day post- induction of the fully kindled state, most GABAA receptor subunit mRNA
levels had returned to control levels with the exception of P3 and y2S/2L levels which
remained elevated. Long-term analysis revealed only a slight decrease in the y2L subunit
in the fascia dentata region of the hippocampus (Kamphuis et al., 1995).
The findings suggest that altered receptor subunit composition may contribute to the
modification of GABAergic inhibitory processes seen in these models. An interesting
observation is the paralleled increase in both GABAA receptor response and selected receptor
subunit expression levels in the hippocampal dentate granule cells in these models, whereas
in the CA regions, a decrease in GABAA receptor function and subunit mRNA levels have
been shown.
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H.

Ca*/Calmodulin-dependent Protein Kinase Il:

Calciwn/calmodulin-dependent protein kinase 11 (CaM kinase II) is a multifunctional
enzyme involved in regulating many Ca++-dependent processes throughout the CNS
(Bronstein et al., 1993). Phosphorylation of substrates by CaM kinase 11 underlies its
modulation of many cellular functions including neurotransmitter biosynthesis and release,
cytoskeletal structure, ligand-gated and calcium-dependent ion channels and transcriptional
regulation (Churn, 1995). The ability of CaM kinase 11 to enhance synaptic function via
phosphorylation of specific glutamatergic receptor channels implicates its involvement in
long-term potentiation (LTP), a model of learning and memory (Soderling, 1993). The
holoenzyme is composed of two subunits termed a and P with apparent molecular weights
of 50 and 60 kDa (kilodaltons) respectively (Goldeming et al., 1983).
A unique characteristic of CaM kinase II is that upon activation by Ca<+ and
calmodulin, the enzyme undergoes autophosphorylation, rendering it ca++/calmodulin
independent. Autophosphorylation allows CaM kinase II to regulate itself and allows for
prolonged activity of the enzyme until selected phosphatases act to return it to its inactive
form. CaM kinase II is expressed abundantly throughout the CNS comprising approximately
l % of total brain protein and up to 2% of total hippocampal protein (Erondu and Kennedy,
1985). The a subunit of CaM kinase II has been designated the major postsynaptic density
(PSD) protein, contributing up to 50% of the total protein in this complex. The PSD is an
electron dense region localized at the postsynaptic membrane of excitatory synapses and is
believed to be involved in maintaining structure and function of the postsynaptic complexes
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(Churn, 1995). The actions of CaM kinase II in regulating so many neurophysiological
processes demonstrates the essential function this enzyme serves in maintaining cellular
viability.
I.

CaM Kinase II in Models of Neuropathology:

Considering the important role that CaM kinase II plays in many neurophysiological
processes, one might expect that alterations in CaM kinase II activity could provoke
neuropathological circumstances. A decrease in forebrain CaM kinase II activity has been
shown to occur immediately following ischemic insult in the gerbil model of ischemia,
preceding the delayed neuronal cell death noted with this model (Churn et al., 1990; Churn
et al., 1992a; Churn et al., 1992b). NMDA-dependent excitotoxicity in primary neuronal
cultures results in a reduction in activity ofCaM kinase II in both hippocampal (Churn et al.,
1995) and cortical (Churn et al., 1995; Churn et al., 1993b) neurons. Several studies have
correlated the extent of excitotoxicity-induced neuronal cell death with the degree of
suppression of CaM kinase II activity. Churn et al. (1990) have shown that hypothermia
induced blockade ofischemic neuronal cell death in gerbil brain also results in preservation
of CaM kinase II activity. Hanson and colleagues (1994) have demonstrated, using a focal
ischemia model in rat brain, that the decrease in level of neuronal death observed with
increased distances from the ischemic core parallels the changes in CaM kinase II activity
seen in this model. The evidence strongly suggests a role for alterations in CaM kinase II
function mediating the aberrant cellular events in excitotoxicity which ultimately result in
the neuronal death associated with these models.
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J.

Alterations in CaM kinase II in Models of Seizures:
In models of seizures and epilepsy Ca++-dependent regulatory processes have been

suggested to play an essential role in the induction and maintenance ofthe pathophysiology
observed (DeLorenzo, 1986). The role ofCaM kinase II in regulating seizure conditions was
first considered because ofthe ability ofanticonvulsant agents to inhibit Ca++/calmodulin
dependent protein phosphorylation and neurotransmitter release (DeLorenzo, 1984). A
number oflaboratories have studied the function ofCaM kinase II in association with the
initiation and maintenance ofseizure expression using a variety ofin vivo and in vitro model
systems. Treatment ofhippocampal slices with Mg++ -free media results in the expression
ofepileptiform activity with a concurrent decrease in activity ofCaM kinase II (Churn et al.,
1991).
A decrease in the function of CaM kinase II in association with status epilepticus
(SE) has been observed in a number ofstudies (Bronstein et al., 1988; Perlin et al., 1992)
Using a continuous hippocampal stimulation (CHS) paradigm to induce status epilepticus
in the rat, Perlin et al. (1992) have shown a significant decrease in activity ofCaM kinase II.
The status epilepticus-induced suppression of CaM kinase II directly correlates with the
progressive intensity ofelectroencephalographic discharges recorded from SE rats. Several
studies have demonstrated a decrease in function of CaM kinase II associated with the
kindling model ofepilepsy in the rat (Goldenring et al., 1986; Wasterlain and Farber, 1984).
A decrease in the expression of CaM kinase II mRNA has been found acutely in a model of
recurrent limbic seizures (Murray et al., 1995) and long-term in the kindling model of
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epilepsy (Bronstein et al., 1992). In light of the results presented from these investigations,
chronic decreases in function of CaM kinase II occur with seizures and epilepsy and may
contribute to the underlying mechanisms of these conditions.
K.

CaM Kinase II Regulation of GABAA Receptor Function:
Consensus sequences for CaM kinase II-dependent phosphorylation have been found

in P l , P2 and y2 GABAA receptor subunits (McDonald and Moss, 1994). A number of
studies have shown enhancement of GABAA receptor function by activation of the CaM
kinase II pathway. Using both spinal dorsal horn neurons and CAI hippocampal neurons,
Wang et al. (1995) demonstrated that an intracellularly applied auto-phosphorylated form of
o:-CaM kinase II increased GABA currents, sensitivity to the GABAA receptor agonist
muscimol and inhibitory postsynaptic potential (IPSP) amplitude in CAI neurons. In a
cerebellar Purkinje cell neuronal model, activation of excitatory synaptic input induces a
rebound potentiation of GABA-mediated currents (Kano, 1994). Studies were carried out
to determine the pathway(s) involved in inducing the change in inhibitory response
associated with this model. First, it was demonstrated that incubation with the calcium
chelator BAPTA ([l ,2-bis(2)-aminophenoxy]ethane-N,N-N',N'-tetraacetic acid) blocked
the potentiation of GABA-mediated currents, suggesting a calcium-dependent mechanism.
Addition of staurosporine (non-selective kinase inhibitor) or KN62 (selective CaM kinase
II inhibitor) both resulted in a blockade of the rebound potentiation. Secondly, the addition
of calyculin-A (inhibitor of protein phosphatase I and 2A) significantly enhanced GABA
induced currents in Purkinje neurons, suggesting a phosphorylation-dependent mechanism.
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Finally, it was demonstrated that intracellular application of a purified and active form of
CaM kinase II into Purkinje neurons resulted in dramatic augmentation of GABA responses
(Kano, 1994). Churn and DeLorenzo (1996) have demonstrated that addition of purified rat
brain CaM kinase II to synaptic membrane preparations acts to dramatically increase [3H]
muscimol binding. The increase in muscimol binding can be blocked by selective inhibitors
of CaM kinase II. These findings strongly suggest a role for CaM kinase II in the positive
modulation of GABAA receptor function.
L.

Summary and Rationale
Epilepsy and seizures represent a major dilemma in healthcare today and affects

approximately 1 % of the adult population (Hauser and Hesdorffer, 1990). Advancement has
been made in the successful management of epilepsy with the use of pharmacological
intervention, but relatively little is known about the maladaptive processes that are
responsible for this condition. The underlying mechanisms of epileptogenesis have been the
focus of many research studies, encompassing the examination of a broad range of cellular
processes. These include regulation of excitatory and inhibitory receptor systems, signal
transduction pathways, synaptic reorganization and transcriptional control of long-term
genes. Considering the complexity of the cross-talk and intra dependency that many of these
cellular processes possess, it is likely that alterations in a number of these systems are
involved in the generation and propagation of seizures.
One direction of investigation has been the study of modifications in GABAergic
function as a contributing factor to seizure production. A decrease in inhibitory drive

21
associated with seizures has been well established in a number of models. Using the in vitro
hippocampal neuronal culture model of spontaneous recurrent seizures (Sombati and
DeLorenzo, 1995), Gibbs and colleagues (1997b) demonstrated a decrease in GABAA
receptor response to both GABA and the benzodiazepine clonazepam. The underlying
cellular alterations responsible for the long-lived change in GABAA receptor function
observed in these hippocampal neuronal cultures and other models of epilepsy have yet to
be determined.
Another direction in elucidating the mechanisms of epileptogenesis has been the
study of Ca++/calmodulin-dependent protein kinase II, a major ca++ second messenger system
that regulates many neuronal functions. Due to the multifunctional nature of CaM kinase
II, alteration of this enzyme system would be expected to invoke abnormal changes in
cellular function. Changes in CaM kinase II activity have been associated with a number of
models of neurotrauma. In particular, a number of studies have demonstrated a decrease in
CaM kinase II function associated with the induction and maintenance of seizures and
epilepsy.
M.

Hypothesis
The hypothesis to be tested in this dissertation is: To determine 1) if alterations in the

GABAA receptor system are associated with the induction and long-term expression of the
"epileptic condition" exhibited in the hippocampal neuronal culture model of recurrent
spontaneous seizures, and 2) if modification of the multifunctional CaM kinase II enzyme
system is associated with the propagation of aberrant activity in this model. The conclusion
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of this dissertation will involve investigating the relationship between CaM kinase II activity
and regulation of GABAergic inhibitory processes in primary hippocampal neuronal cultures.
The experiments in this thesis study will be directed towards testing this hypothesis.

DECREASED GABAA RECEPTOR EXPRESSION IN AN IN VITRO
IDPPOCAMPAL NEURONAL CULTURE MODEL OF RECURRENT
SPONTANEOUS SEIZURE

A.

INTRODUCTION:
y-Aminobutyric acid (GABA) acts to mediate inhibitory processes throughout the

brain by its action on GABAA and GABA8 receptors (Bowery et al., 1987). Nearly every
neuron in the brain responds to GABA in a inhibitory fashion, as well as non-neuronal cells
such as glia (Burt and Kamatchi, 1991). Suppression of inhibitory mechanisms by
modulation of GABAA receptor function has been suggested to contribute to the
neuropathological conditions ofseizures and epilepsy. This theory ofepileptogenesis can
be postulated by several lines ofevidence. First, many of the pharmacological agents used
to manage seizures and epilepsy act at the GABAA receptor to augment the inhibitory
function of the chloride channel and secondly, convulsant agents such as picrotoxin or
bicuculline produce their effects by antagonizing GABAA receptor function. A substantial
amount ofresearch has been conducted to investigate modifications in GABAergic inhibitory
processes in models of seizures and epilepsy. One theory termed the "dormant basket cell
hypothesis" suggests that a selective seizure-induced loss ofexcitatory neurons in the dentate
23
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gyrus and subsequent removal oftheir afferent projections onto GABAergic intemeurons,
results in a hindrance of the inhibitory pathway from this region (Dudek and Spitz, 1997).
Such a mechanism implies that the inhibitory mechanisms remain intact, but are incapable
of being activated.
Another direction of epilepsy research involves investigating postsynaptic
mechanisms ofseizure induction; specifically modifications ofthe GABAA receptor channel.
Indications of seizure associated changes in GABAA receptor function include a decrease in
benzodiazepine sensitivity (Kapur et al., 1994; Kapur and Macdonald, 1997), reduction in
muscimol binding (Rice et al., 1996), suppression of inhibitory conductances (Merlin and
Wong, 1993), and increased Zn++ sensitivity (Buhl et al., 1996). A reduction in paired-pulse
depression, an indicator ofGABAergic inhibitory function, has been demonstrated in both
the continuous hippocampal stimulation model ofSE (Kapur and Lothman, 1989) and the
kindling model ofepilepsy (Kapur et al., 1989). Although there has been much progress in
understanding epilepsy-associated changes in GABAA receptor function, the underlying
molecular mechanisms ofthese maladaptations still remain unclear.
Molecular cloning studies have recently demonstrated the existence of at least 13
different GABAA receptor subunits throughout the CNS which include 6 as, 3 Ps, 3 ys and
l o (McKeman and Whiting, 1996). The diverse expression patterns for each subunit
parallels region-dependent variations in GABAA receptor function, indicating that receptor
subunit composition underlies functional heterogeneity.

Expression studies have

demonstrated differential sensitivity ofrecombinant GABAA receptors to benzodiazepines
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dependent on which ex subunit is present in the receptor complex (Luddens et al., 1995). The
regional expression ofthe ex 1 subunit parallels high affinity (Type I) BZ (benzodiazepine)
binding. It is believed to primarily co-assemble with the P 2 and y 2 subunits, a receptor
combination that displays diffuse distribution and is estimated to constitute greater than 50%
ofall GABAA receptors in the brain. Low affinity (Type II) BZ receptor binding exhibits a
more selective distribution pattern concentrating primarily in the hippocampus, striatum and
spinal chord, correlating with ex 2, a 3, and a 5 subunit expression patterns (Burt and
Kamatchi, 1991). The differential subunit expression and functional diversity ofGABAA
receptors observed throughout the brain suggest that transcriptional control may be a primary
means of regulating receptor heterogeneity.
Seizure induced alterations in transcriptional control of GABAA receptor subunit
expression could contribute to the neuropathophysiological consequences associated with the
epileptic condition. A number of investigations have studied changes in expression levels
for selected GABAA receptor subunit mRNAs in models of seizure and epilepsy. A long
lasting decrease in mRNA expression for selected GABAA receptor subunits has been shown
to be associated with persistent SRSs in pilocarpine-induced epileptic animals (Rice et al.,
1996) and in low Mg..-evoked SRSs in hippocampal entorhinal cortical slices (Vick et al.,
1996). Changes in the expression levels for GABAA receptor subunit mRNA have also been
demonstrated in the kainic acid model oftemporal lobe epilepsy (Friedman et al., 1994) and
electrically-induced kindling model of epilepsy (Kamphuis et al., 1994). In addition to
changes in GABAA receptor expression, increase in the expression of selected transcription

26
factors such as c-FOS, c-JUN, KR.OX, and CREB have been shown to occur in the early
phases of epileptogenesis (Herdegen et al., 1993; Labiner et al., 1993). These immediate
early genes (IEGs) are responsible for regulating transcriptional control and expression of
Jong-term effector genes. Alterations in regulation of these factors could contribute to long
lasting maladaptations in neuronal function.
To investigate the effect ofepileptogenesis on GABAA receptor subunit expression,
we have employed the hippocampal neuronal culture model of epilepsy (Sombati and
DeLorenzo, 1995). Treatment ofhippocampal cell cultures with a Mg++-free media for three
hours results in the induction ofan enduring "epileptic" state as evidenced by the expression
ofspontaneous recurrent seizure (SRS) discharges. The seizures exhibited in this model can
be halted by classical anticonvulsant drugs; this blockade is reversible, where upon removal
of the drug results in resurgence of the seizure discharges. A permanent and long-lived
alteration is in place in this model and underlies the chronic expression of the
pathophysiological condition. Reducing extracellular ca++ to 0.2 mM or applying 50 µM
APV during the treatment protocol blocks the induction ofthe "epileptic" condition in these
cultures, suggesting an NMDA receptor, ca++-dependent mechanism is involved in the
induction of SRS activity evidenced in these hippocampal cultures. The ability to easily
evaluate and control the neuronal culture environment makes this model a powerful tool for
the investigation of the biochemical, biophysical and genetic mechanisms that underlie
epilepsy and the seizures associated with it.
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B.

METHODS:

Primary Hippocampal Neuronal Cultures:

Primary hippocampal cultures were prepared by a modification of the method of
Banker and Cowan (1979) as described by Sombati et al. (1991). Briefly, hippocampi from
2-day postnatal Spague-Dawley rat pups were dissected out from the brain and placed into
phosphate buffered saline (PBS) dissection solution containing: 33.0 mM glucose, 43.8 mM
sucrose,

penicillin

(50

units/ml)/streptomycin

(50

µg/ml),

IO

mM

N-2-

hydroxyethylpiperazine-N' -2-ethanesulfonic acid (HEPES), (pH 7.3) and adjusted to 325
mOsm with sucrose. Meningeal tissue was stripped away under 40X magnification using
a Zeiss dissecting microscope (Zeiss, West Germany) and hippocampi were then transferred
to dissection saline containing 0.25% trypsin (Gibco BRL, Gaithersburg, MD) and incubated
at 37 ° C for 20 minutes for enzyme digestion. Trypsinized hippocampi were washed with
dissection saline (no trypsin), brought up to a 2.0 ml volume with 10% fetal bovine serum
in minimum essential medium (MEM) (Gibco BRL, Gaithersburg, MD) containing penicillin
(SO units/ml)/streptomycin (SO µg/ml) and triturated by passing through a Pasteur pipet.
Trituration involved passing the hippocampal tissue suspension through the pipet 20 times
and then allowing suspension to pellet. Dissociated hippocampal cells were drawn off and
pooled. The peUet was adjusted to a 2.0 ml volume and re-triturated. This procedure was
repeated two more times until very little tissue pellet was remaining. Viable hippocampal
cells were counted using cresyl violet blue exclusion analysis with a hemocytometer on a
Nikon TMS microscope at 200X magnification (Nikon, Japan) and the suspension was
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adjusted to I x I 06 cells/ml. Hippocampal cells were plated at a density of 2 x 105 cells/35
mm culture dish (Nalge Nunc International, USA). Prior to plating, dishes were coated with
10 µl of growth factor reduced MATRIGEL® matrix (Collaborative Biochemical, Bedford,
MA) to aid in the attachment of the hippocampal cells. Hippocampal cells were plated in
MEM containing N3 supplement media, 10% horse serum, 20% conditioned media and
penicillin (50 units/ml)/streptomycin (50 µg/ml). The N3 supplement contained: 25 mM
HEPES buffer (pH= 7.4), 2 mM glutamine, 5 µg/ml Insulin, 100 µglml transferrin, 100 µM
putrescine, 30 T)M sodium selenite, 20 T)M progesterone (ICN, Costa Mesa, CA), 1 mM
sodium pyruvate, 0.1% ovalbumin, 20 t]g/ml T3 (Calbiochem, San Diego, CA), 40 T)g/ml
corticosterone (ICN, Costa Mesa, CA). Unless indicated, all other constituents of the N3
supplement were acquired from Sigma Chemical Co., St. Louis, MO. One day following
plating, the media was replaced with N3 supplement containing 20% conditioned media and
5 µM cytosine arabinoside to inhibit further non-neuronal cellular proliferation. After two
days of incubation in 5 µM cytosine arabinoside, media was replaced with N3 supplement
containing 20% conditioned media. The hippocampal cultures were maintained in this media
for the remainder of the study and were fed with Y, change of media at one week intervals.
Conditioned media was obtained from confluent hippocampal glia beds plated out at a
density of l.Oxl06 cells/75 cm2 flasks and maintained in MEM containing 10% fetal bovine
serum and 2 mM glutamine. Glial cell beds reached confluence 10 days after plating and
were fed with full change of media twice weekly. Both hippocampal cell cultures and glia
beds were maintained at 37 oC under 5% CO2 95% air.
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Mg -free Treatment ofHippocampal Cell Cultures:

After two weeks in culture, maintenance media was replaced with exposure solution
containing (in mM): 145 NaCl, 2.5 KCI, 10 HEPES, +/- 1 MgCl2, 2 CaCl2, 10 glucose, .002
glycine, pH 7.3, and osmolarity adjusted to 325m0sm with sucrose. Cells were washed
gently with 3 x 1.5 ml of exposure solution with +/- 1 mM MgCl2 and then allowed to
incubate in this solution for 3 hours at 37 °C under 5% CO2 95% air. At the end of
treatment, cells were washed gently with 3 x 1.5 ml ofMEM at 37 °C, and then media was
replaced with maintenance feed and treated cultures were left undisturbed for specified time
points post-treatment.
Isolation of poly-(A)+ RNA from hippocampal neuronal cultures:

At specified times after experimental manipulations, hippocampal neuronal cultures
were taken and poly-(A)+ RNA was isolated using the Micro-FastTrack™ Kit (Invitrogen
Corporation, San Diego, CA). Briefly, each 35 mm culture dish was rinsed with phosphate
buffered saline and then harvested in 1.0 ml of lysis buffer containing RNAase/Protein
degrader. Cells were aspirated off of the culture plate into lysis buffer using a 1.0 ml syringe
with an 18G needle, and then transferred to a 1.7 ml microfuge tube. Three 35 mm plates
were sequentially pooled into 1.0 ml oflysis buffer to maximize yield of mRNA. Lysates
were then incubated at 45 °C for I 5-20 min in a shaking H20 bath to allow for digestion of
proteins and ribonucleases. Lysates were then adjusted to a 0.5M NaCl concentration ,
mixed thoroughly, and DNA was sheared by passing lysates through a 1.0 ml syringe with
a 18-20 gauge needle 3-4 times. One Oligo (dT) cellulose tablet was added to each tube and
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allowed to go into suspension by gently agitating microfuge tube. Once Oligo (dT) cellulose
was in suspension, samples were placed on rotator for 20 min at room temperature to allow
for maximum hybridization ofpoly-(A)+ RNA to Oligo (dT). Samples were then centrifuged
at 4,000 x g for 6 min in a micro centrifuge to pellet Oligo (dT) cellulose. The supernatant
was then aspirated off, and the pellet was washed by gently resuspending in 1.3 ml binding
buffer. Oligo (dT) cellulose was then pelleted by centrifugation at 4,000 x g for 6 min..
Pellets were washed in binding buffer until supernatant was no longer cloudy (3-4 times).
After last wash, Oligo (dT) cellulose was transferred in a 0.3 ml vol ofbinding buffer to a
spin-column/microfuge tube assembly. The assembly was centrifuged for 10 sec at 5,000
x g, and eluant was discarded. The Oligo (dT) column was washed by adding 0.8 ml of
binding buffer and quick spinning micro centrifuge. This was repeated 3 times to ensure
removal ofDNA from column. Non-polyadenylated RNA was removed by re-suspending
column in 0.2 ml oflow salt wash and spun down. Low salt wash was repeated once more.
Oligo (dT) columns containing poly-(A)+ RNA were transferred to new rnicrofuge tubes.
Poly-(A)+ RNA was eluted off the column by suspending cellulose in 0.1 ml of elution
buffer and spun down in micro centrifuge. This was repeated to yield a 0.2 ml volume of
elution buffer containing the poly-(A)+ RNA. Poly-(A)+ RNA was precipitated by adding
10 µl ofglycogen (supplied as 2 mg/ml), 30 µI of2 M Sodium Acetate and 600 µI of200
proofethanol, and stored at - 70 °C for a minimum of 16 hours. Poly-(A)+ RNA was then
pelleted by spinning at 16000 x g for 30 min in a micro centrifuge at 4 °C. Supernatant was
removed and pellets were washed with 70% ethanol and then re-centrifuged for 30 min. at
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4 cc. Supernatant was removed, and pellets were dried in a speed-vac (Savant Instruments,
Inc., Holbrook, NY). Poly-(A)+ RNA pellets were then re-suspended in 100 µI ofDEPC
treated (RNAase-free) H20 and stored at - 70 cc until used. All reagents and materials used
for poly-(A)+ RNA isolation were treated to be RNAase-free. Total RNA was isolated from
adult rat brain using the guanidinium thiocyanate-phenol-chloroform method previously
described (Chomczynski and Sacchi, 1987).
Northern Blot and Slot Blot of Poly-(A)+ RNA onto Nitrocellulose:

Northern blots were carried out by standard techniques (Maniatis et al., 1982a).
Briefly, denatured poly-(A)+ RNA was electrophoresed through a formaldehyde-containing
1.0% agarose gel. After electrophoresis, the gel was briefly rinsed in RNAase-free Hp and
treated for transfer by hydrolyzing in 50 mM NaOH, l O mM NaCl for 45 min. The gel was
neutralized in 100 mM Tris-Cl (pH 7.5) for 45 min and then soaked in 20X SSC for 60 min.
The poly-(A)+ RNA was allowed to transfer for 12-16 hours onto BASS nitrocellulose
membrane (Schleicher & Schuell, Keene, NH) by capillary elution. The Northern blot was
briefly rinsed in 3X SSC and allowed to thoroughly air dry for 1-2 hours. The RNA blot was
baked at so c c under vacuum for 2 hours. Slot blots were prepared by vacuum filtration of
denatured poly-(A)+ RNA onto BASS nitrocellulose membrane using the MINIFOLD® II
slot-blot system (Schleicher & Schuell, Keene, NH). Slot blots were then soaked in 3X SSC
for 5 min and allowed to air dry. The RNA slot blot was baked at so c c under vacuum for
2 hours.
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Cloning of cDNAs for GABAA-receptor subunits:

Synthesis of first strand cDNA from rat hippocampal RNA was carried out using
reverse transcription. Briefly, reverse transcription reactions contained 500 T)g of RNA, 5.0
mM MgCl2, IX PCR buffer, 1.0 mM dNTPs, 20 mM OTT, 0.5 µI RNasin and 1.0 µI
SuperScript™ II Rnase H Reverse Transcriptase (Gibco BRL, Gaithersburg, MD) in a 10 µI
volume. Prior to adding reverse transcriptase, samples were denatured by incubating at 70 °c
for 10 min. Reactions were initiated by addition ofthe reverse transcriptase and then allowed
to incubate at 42 ° C for 60 min. Twenty-five base synthetic oligonucleotide primers were
constructed (Operon Technologies, Alameda, CA) against specific GABAA receptor subunits
using published sequences available from the GCG (Genetics Computer Group, University
of Wisconsin); al: L08490 (Draguhn et al., 1990), a2: L08491 (Wisden et al., 1992), a5:
L08494 (Pritchett and Seeburg, 1990), P2: X15467 (Ymer et al., 1989) and y2: L08497
(Shivers et al., 1989). The selected regions of published cDNA sequences that were
amplified for each receptor subunit were: al (1013- 1645), a2 (1269-1529), a5 (1219-1749),
p2 ( I 276-1840), and y2 (1185-1604). PCR amplification was carried out in a PTC-100™
programable thermal controller (MJ Research, Inc., Watertown, MA); reactions contained
5 µM each of upstream and downstream primers, 1 mM dNTPs, IX PCR buffer, 2.5 mM
MgC12 , cDNA from reverse transcribed hippocampal RNA and 1 unit of Taq polymerase
(Promega, Madison, WI) in a final volume of 50 µI. Amplified products were checked by
electrophoresis on 2.0% agarose gel and ethidium bromide stained to confirm presence and
expected size of cDNA. PCR products were then cloned using the Original TA Cloning® Kit
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(Invitrogen , San Diego, CA). Briefly, I: I, I: I 0, I: I 00 dilutions of confirmed inserts were
ligated into pCR™ 2.1 vector at 14 ° C overnight. Ligation reactions included (in µl): 1.0
diluted PCR product, 1.0 !OX ligation buffer, 2.0 pCR™ 2.1 vector (2511g!µl), 6.0 sterile
H20, 1.0 T4 DNA ligase (4.0 Weiss units). Ligated products were transformed into One
Shot™ cells (INVaF'). Competent cells (50 µI/vial) were treated with 2.0 µl ofSM P-ME
by stirring in with pipet tip. Two microliters ofligation reaction were added to competent
cells and mixed gently. Cells were incubated on ice for 30 minutes, heat shocked for 30
seconds in a 42 ° C Hp bath and placed back on ice for 2 minutes. 450 µI ofSOC medium
was added to each vial and incubated for 1 hour at 37 ° C in a rotary shaker (225 rpm). Fifty
µI and 200 µI ofeach transformation was spread onto LB agar plates containing 50 µg/ml
ampicillin and previously treated with 40 µIX-Gal (40 mg/ml). Plates were incubated at
37 ° C inverted for a minimum of18 hours. Ten white colonies were selected from each plate
and grown overnight in 2 ml ofLB broth containing 50 µg/ml ampicillin at 37 ° C. A volume
of1.5 ml ofthe each cell suspension was utilized for mini plasmid DNA preparations carried
out by alkaline lysis technique as previously described (Maniatis et al., 1982b), restriction
enzyme digested and run out on 2.0% agarose gel to confirm presence and size of insert.
Once presence of insert was confirmed, large scale plasmid preparations were carried out and
DNA was isolated using the cesium chloride extraction technique (Virginia Commonwealth
University/Medical College of Virginia - Microbiology Core Facility)
Sequencing of cDNAs:

Sequencing of cDNAs was performed using the protocol for di-deoxy chain-
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terminating reactions from previously established techniques (Sanger et al., 1977). Briefly,
plasmid DNA was denatured by NaOH followed by ethanol precipitation. GABAA receptor
cDNAs were added with either Ml3 reverse or forward primers. This mixture underwent
denaturation for 2 min at 65 ° C and then cooled slowly to allow for proper annealing of
primers. Labeling reactions were initiated by the addition of labeling mix containing dNTPs,
Sequenase T7 polymerase (United States Biochemical, Cleveland, OH) and [35S]-o:-dATP
(DuPont-NEN, Boston, MA) to the annealed DNA mixture and incubated at room
temperature for 5 min. Four equal aliquots of labeling reaction were added to four tubes each
containing different terminating di-deoxy nucleotides (ddTTP, ddGTP, ddATP and ddCTP)
and the reactions were allowed to continue for l O min at 37 ° C. Reactions were then stopped
with the addition of stop solution. Labeled samples were denatured at 90 °C for 2 min and
immediately electrophoresed on a denaturing urea sequencing gel. Sequencing gels were
dried and exposed to X-OMAT x-ray film (Kodak, Rochester, NY) for autoradiographic
visualization. Sequences were read by hand and compared to published sequences from the
GCG (Genetics Computer Group, University of Wisconsin) for conformation of correct
cDNA insert.
Radiolabeling of DNA Probes:
cDNA probes were radiolabeled using the Random Primers DNA Labeling System
(Life Technologies, Gaithersburg, MD). Briefly, 25-50 µg of cDNA was dissolved in 20 µI
of dH20 and denatured by heating for 5 min in a boiling water bath and then immediately
cooled on ice. 2 µl each of0.5 mM dGTP and 0.5 mM dTTP, 15 µl Random Primers Buffer,
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5 µl each of [a- P]dCTP and [a- 2P]dATP (3000 Ci/mMOL,DuPont-NEN, Boston, MA)
was added. The labeling reaction was initiated by the addition of I µl Kienow fragment (3
units/µ!) and incubated at 25 ° C for I hour. Radiolabeled probes were purified using the TE
MIDI Select®-D, G-50 micro-centrifuge spin columns (5 Prime-+3 Prime, Inc.®, Boulder,
CO).

Poly d(T) oligonucleotide was end-radiolabeled with (32P]-y-ATP (DuPont-NEN,

Boston, MA) using T4 polynucleotide kinase (Gibco BRL, Gaithersburg, MD). Labelled
probe was purified using the TE MIDI Select®-D, G-25 micro-centrifuge spin columns (5
Prime-+3 Prime, Inc.®). Specific activity was determined for all radiolabeled probes by
counting 1.0 µI of purified probe on a Beckman LS 6500 scintillation counter (Beckman
Instruments Inc., Fullerton, CA).
Hybridization Analysis of RNA Blots:

RNA blots were prehybridized at 42 ° C for 12-16 hours in hybridization solution
containing: 50 mM NaH2P04, 3X SSC, 5X Dendhardt's, 50% deionized formamide, 200
µg/ml tRNA and I% salmon testes DNA. Hybridization with the specific GABAA subunit
cDNA probes was carried out by adding 1-2 x I 06 CPM (counts per minute) of radiolabeled
probe/ml of hybridization solution and allowed to incubate at 42 ° C for 12-16 hours in a
shaking HzO bath. After hybridization, RNA blots were washed 3 x 10 min at 60 ° C in a IX
SSC, 0.1% sodium dodecyl sulfate (SDS) solution. For the poly d(T) oligonucleotide
hybridization, 1-2 x 106 CPM of radiolabeled probe was added per ml of hybridization
solution containing: 5X Denhardt's, 5X SSPE, 200 µg/ml tRNA, 0.5% SDS and 15%
deionized formamide. Poly d(T) oligonucleotide hybridized blots were washed 3 x 5 min at
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37 C in a 2X SSC, 1.0% SDS solution. Washed blots were then exposed to either X-Omat
film (Kodak, Rochester, NY) or a phosphor screen (Molecular Dynamics, Sunnyvale, CA)
for varying durations to acquire correct exposure. Phosphor screens were scanned on a
Phosphor lmager and hybridization signal was analyzed using lmageQuant software
(Molecular Dynamics, Sunnyvale, CA).
GABAA a2 Antisense Oligonucleotide Knockdown Analysis:

Antisense and missense oligonucleotide probes were constructed (Operon
Technologies Inc., Alameda, CA).

For the GABAA a2 knockdown, an antisense

oligonucleotide complementary to the + 1 to + 18 nucleotides was constructed with the
following sequence: 5' CAA CCT GGC TGG GTC CAC 3'; missense GABAA a2 sequence
was as follows: 5' CAA CCG TCG TGG GTC CAC 3'. Hippocampal neuronal cultures were
treated for 5 days with 1.0 µM of either antisense or missense oligonucleotides every 24
hours.

During the treatment regimen, hippocampal cultures were maintained in N3

supplement containing 20% conditioned media at 37 ° C under 5% CO2 95% air. At the end
of the 5 day treatment protocol, cultures were utilized for electrophysiological analysis.
GABAA Receptor p Subunit Immunoreactivity:

Four to six micrograms of balanced proteins were blotted onto Trans-Blot®
nitrocellulose membrane (Bio-Rad, Hercules,CA) under vacuum filtration using a PR 600
slot blot apparatus (Hoefer Scientific Instruments, San Francisco, CA). Antibody blot
analysis was carried out using a Vectastain® ABC alkaline phosphatase staining kit (Vector
Laboratories, Burlingame, CA). Briefly, protein blots were incubated overnight at 4 °C on
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a rotary shaker in a PBS-blocking solution containing: 5.0% dry milk(w/v), 0.05% TWEEN20 and 0.0 I% anti-foam. Blots were then incubated in PBS-blocking solution containing a
primary antibody specific for the GABAA receptor� chain(monoclonal lgG, clone bd 17:
Boehringer Mannheim Biochemica, Indianapolis, IN) for I hour on rotary shaker at room
temperature. Unbound antibody was removed by 3 washes in PBS-blocking solution. Blots
were then incubated with a biotinylated secondary antibody in PBS-blocking solution for 30
min at room temperature. Excess secondary antibody was removed by 3 washes with PBS.
Labelled proteins were reacted with a peroxidase substrate solution and allowed to develop.
The staining reaction was stopped by washing in several changes of dH20. Developed
membranes were allowed to air dry, digitized using a HP ScanJet 4C/T high resolution
scanner (Hewlett Packard, Boise, ID) and intensity measurements were obtained using a
computer-assisted densitometer(Mocha0, Jandel Corp., San Rafael, CA).
Photoaffinity Labeling of [3H)-Flunitrazepam to Hippocampal Culture Membranes:
Photoaffinity labeling of the BZ receptors was carried out by modification ofmethods
previously described (Bowling and DeLorenzo, 1987; Mohler et al., 1980). Three days
following low Mg++ treatment, hippocampal neurons were washed twice with exposure
solution(+ 1.0 mM MgC12) at 37 ° C. The wash solution was rapidly replaced with ice-cold
homogenization buffer containing: 50 mM Tris-Citrate(pH 7.2) and 0.32 M sucrose and the
cells were immediately scraped from the culture dish surface. The cell suspension was
transferred into a glass homogenizer(Kontes, Vineland, NJ), and disrupted with IO strokes
of the homogenizer. To obtain a crude P-2 membrane preparation, homogenates were
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centrifuged at 18000 x g for 30 min. Membrane fractions were washed three times in 50 mM
Tris-Citrate buffer (pH 7.2). Washed membrane preparations were normalized for protein
using a micro-Bradford reagent system (Bio-Rad, Hercules,CA). Saturation flunitrazeparn
(FNZ) binding reactions were carried out as previously described (Bowling and DeLorenzo,
1987; Mohler et al., 1980). Briefly, reaction volumes of 100 µI contained P-2 protein (15 µg)
and 40 11M [3H]-FNZ (85 Ci/mMOL, DuPont-NEN, Boston, MA) ± 40 µM cold FNZ.
Reactions were allowed to reach equilibrium at 4 °C for 2 hours. The FNZ was covalently
bound to P-2 membrane by exposure to UV light (1500 µW/cm2/sec; UVP Products, Upland,
CA) at 4 °C for 30 min. Photoaffinity labeled membrane proteins were resolved by SDS
p AGE. The SDS-PAGE gel was Coomassie stained and sliced in mm fractions from the
origin to the dye front. Gel slices were digested in HP2, INSTA-GEL® XF scintillation
fluid (Packard, Meridan, CT) was added and the [3 H]-FNZ per slice was quantitated on a
Beckman LS 6500 scintillation counter (Beckman Instruments Inc., Fullerton, CA). A major
peak of [3H)-FNZ binding was observed in association with the 50 kDa a GABAA receptor
protein as described previously (Mohler et al., 1980) and specific binding was determined
by subtracting non-specific ([3H]-FNZ + cold FNZ) from total binding ([3H)-FNZ alone) in
the 50 kDa a subunit peak.
Electrophysiological Analysis of SRS Activity in Hippo campal Neuronal Cultures:

Electrophysiological analysis was performed using previously established procedures
in our laboratory (Coulter et al., 1992; Sombati et al., 1991). Briefly, cell culture media was
replaced with recording solution containing (in mM) 145 NaCl, 2.5 KC!, 10 HEPES, I
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MgC12, 2 CaC12, 10 glucose, .002 glycine, pH 7.3 and osmolarity adjusted to 325 mOsm with
sucrose. Cultures were then mounted on the stage of an inverted microcsope (Nikon
Diaphot, Japan), continuously perfused with recording solution and then studied using the
whole cell current-clamp recording procedure. Patch electrodes with a resistance of 2-4 MQ
were pulled on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato, CA)
and then fire polished. For whole-cell current-clamp analysis, the electrode was filled with
a solution containing (in mM) 140 K+gluconate , I MgC12 and 10 Na-HEPES, ph 7.2,
osmolarity adjusted to 3 10 ± 5 mOsm with sucrose. Data was digitized and transferred to
video tape using a PCM device (Instrutech, Mineola, NY; 18 kHz sampling frequency) and
then played back on a DC-500 Hz chart recorder (Astro-Med Dash II, Warwick, RI).
Intracellular recordings were carried out using a Axopatch ID amplifier (Axon Instruments,
Foster City, CA) in whole-cell current-clamp mode.
Electrophysiological Analysis of IPSC Amplitudes:

For electrophysiological analysis of spontaneous inhibitory postsynaptic current
(IPSC) amplitude, voltage-clamp recordings were performed using procedures similar to
what was utilized by Soltesz et al. (Soltesz et al., 1995). Briefly, culture medium was
changed to recording solution containing (in mM) I tetrodotoxin (TIX), 25 APV and I 0
CNQX, 145 NaCl, 2.5 KCl, 10 HEPES, 1 MgCl2, 2 CaCl2, 10 glucose, .002 glycine, pH 7.3
and osmolarity adjusted to 325 mOsm with sucrose. Patch electrodes with a resistance of2-4
MQ were pulled on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato,
CA) and then fire polished. The pipet solution contained (in mM) 140 CsCI, 1 MgC12, 10
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HEPES, I. I ethylenebis(oxyethylenenitrilo) tetra acetic acid (EGTA) and adjusted to pH 7.2
with CsOH and 310 mOsm with sucrose. After the patch-clamp was established on a
pyramidal neuron, the membrane potential was clamped at -50 mV and voltage-clamp
recording mode was employed using an Axopatch ID amplifier (Axon Instruments, Foster
City, CA). Data was digitized and transferred to video tape using a PCM device (Instrutech,
Mineola, NY; 18 kHz sampling frequency) and then played back on a DC-500 Hz chart
recorder (Astro-Med Dash II, Warwick, RI). To evaluate the IPSCs, digitization analysis and
detection of individual mIPSCs were done using the Strathclyde Electrophysiology Software
WCP V 1.2 (Dagan Corporation, Minneapolis, MN) and IPSC amplitudes and frequencies
were determined..
C.

RESULTS:
Whole-cell current-clamp analysis was carried out on low Mg++ and sham treated

hippocampal cell cultures at selected time intervals following the treatment protocol.
Electrophysiological analysis of control pyramidal neurons revealed normal activity
exhibited by the presence of spontaneous excitatory postsynaptic potentials (EPSPs), and the
generation of occasional action potentials (Fig. IA). Following low Mg++_treatment,
hippocampal cultures displayed an enduring "epileptic" alteration evidenced by spontaneous
recurrent seizure bursts (Fig. lB), that have previously been shown to range in duration from
20 sec to 2 min with a resting membrane potential of neurons ranging between -50 to -65 mV
(Sombati and DeLorenzo, 1995). Further expansion of one of the "epileptic" bursts revealed
the presence of individual PDSs. Even further expansion revealed the complexity of the
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individual PDSs with a spike frequency discharge of approximately 17 Hz. The expression
of this hyperexcitable state was a permanent alteration in these neuronal cultures in that the
SRS activity has been shown to persist for the life of the culture (Sombati and DeLorenzo,
1995).
To determine if low Mg++ treatment and subsequent induction of SRSs in
hippocampal neuronal cultures resulted in alterations in cellular density and morphology,
photomicrographs were obtained from the same field of neurons in culture at different
intervals during the treatment protocol. Prior to low Mg++ treatment, neuronal morphology
was characterized by a extensive network of dendritic processes and presence of defined
neuronal somata (Fig. 2A). Photomicrographs obtained from neuronal cultures one day (Fig.
2B) and three days (Fig. 2C) post low Mg++ exposure demonstrated no gross alterations in
neuronal culture morphology or density in association with the SRSs evident in this model.
Other work from this laboratory demonstrated that low Mg++ treatment resulted in a modest
decrease of 6.8% in cell counts compared to control 2 days following induction of SRSs
(Gibbs et al., 1997b). These findings demonstrated that there were no gross changes in
neuronal culture morphology or density associated with the "epileptic" condition observed
in this model.
Sequence analysis by the di-deoxy chain-termination method (Sanger et al., 1977)
demonstrated that the cDNA clones constructed for the al, a2, a5, �2 and y2 subunits of the
GABAA receptor had the correct sequences as compared to those published in the GCG
(Genetics Computer Group, University of Wisconsin).
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To determine specificity of the cDNA clones constructed to the al , a2, a5, p2, and
y2 GABAA receptor subunits, random primer labeling of cDNA probes and subsequent
hybridization analysis using poly(A)+ RNA Northerns was carried out (Fig. 3). Stringency
conditions were determined to achieve specificity of the hybridized signal. Hybridization
with the al cDNA probe revealed a single mRNA transcript with a length ofapproximately
4.0 kb (kilobases). Other studies have demonstrated the existence oftwo separate bands in
close apposition to each other at approximately 3.8 and 4.3 kb (Khrestchatisky et al., 1989).
Our finding of only one band is probably attributed to lower resolution of resolving the
mRNA samples out on the agarose gel. Two mRNAs were detected with sizes of3.6 and 6.6
kb when Northern blots were probed with the cDNA specific for the GABAA a2 subunit.
These findings agreed with a previous study performed by Khrestchatisky et al. (1991). A
single mRNA species 2.8 kb in size was detected using the a5 subunit cDNA probe which
agrees with established findings (Pritchett and Seeburg, 1990). Single mRNAs were detected
at 8.0 and 4.2 kb for the p2, and y2 cDNAs respectively.
To evaluate changes in mRNA levels for the GABAA receptor subunits associated
with this model ofSRS, Poly(A)+ RNA was isolated from control and "epileptic" cultures
at various time intervals, and hybridization blot analysis was carried out using the selective
cDNA probes complementary to the GABAA receptor subunits. Oligo-d(T) hybridization
was used to normalize for poly-(A)+ RNA loadings. One day following the induction of the
SRSs in the neuronal cultures, a significant decrease in mRNA levels of 20.2±3.1 % (p =
0.04, low Mg++: n = 9, sham: n = 14) and 36.7±8.9% (p = 0.05, n = 3) for GABAA a2 and a5
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receptor subunits respectively was observed (Fig. 4). Hybridization analysis of the GABAA
a 1, p2, and y2 subunits revealed no significant changes in expression levels at the one day
time point. 1bree days following low-Mf+ treatment ofneuronal cultures, transcript levels
for the a5 receptor subunit remained significantly decreased by 14.5±3.6% (p = 0.04, low
Mg++: n = 7, sham: n = 8) of control, while a2 returned to basal levels. P2 mRNA
expression remained at control levels at the 3 day time point (Fig. 5).
A number of modulatory sites on the GABAA receptor complex have been
determined, one of which binds the BZs. The action ofBZs on this site act to modulate
GABAA receptor function to produce a number ofneurophysiological effects which include
anxiolytic, antiepileptic, and muscle relaxant. The binding ofBZs has been shown to occur
on the a subunit of the receptor channel, and its affinity for binding selective BZs is
dependent on which member of this class ofGABAA receptor subunits is present (Pritchett
et al., 1989).

We have employed the technique of photoaffinity labeling of [3H]

flunitrazepam (Mohler et al., 1980) to evaluate levels of the 50 kDa a subunit protein in
membranes preparations from control and "epileptic" neuronal cultures 3 days following
induction of SRSs. Irreversible photoaffinity labeling of [3H]-flunitrazepam was carried out,
and reaction proteins were resolved by SDS-PAGE electrophoresis and binding to the 50 kDa
protein was analyzed. A significant decrease of 62.8±3.24% (p = 0.00016, n = 3) in BZ
binding was observed in membranes isolated form "epileptic" neuronal cultures when
compared to sham treated control values (Fig 6).
The use of antisense oligonucleotides to study the function of individual proteins by
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their selective suppression has recently been established and accepted throughout the
scientific community (Pilowsky et al., 1994). The mechanism by which the complementary
antisense oligonucleotide produces a decrease in expression of the target protein is via
hybridization to the specific mRNA transcript and blockade of its translation. We wanted
to determine if the reductions in GABAA receptor subunit mRNA levels observed in this
model are involved in the elicitation of SRSs. To address this question, we constructed an
antisense oligonucleotide probe to the GABAA a:2 receptor subunit to selectively suppress
(knock-down) this protein. Electrophysiological analysis of hippocampal cultures treated
with antisense oligonucleotides specific for the a:2 subunit using the voltage-clamp recording
technique revealed a dramatic reduction in amplitude oflPSCs (Fig. 7A). Quantification of
this analysis demonstrated that a:2 subunit suppression resulted in a significant decrease of
43.3±4.8% (p = 0.00003, antisense: n = 5, missense: n = 6) in IPSC amplitude compared to
missense controls (Fig. 7B). Previous work from our lab has demonstrated that "knock
down" of GABAA a:2 also resulted in a profound state of neuronal hyperexcitability in
hippocampal cultures (Sombati et al., 1995).
To assess ifthe decrease in GABAA receptor function observed in this model of SRSs
is the result of a general reduction in receptor protein expression, a monoclonal antibody
specific for the p subunit family of the receptor was employed. Given that most all GABAA
receptors contain at least one p subunit would indicate that their expression level would
reflect that of the whole receptor complex. Homogenates were prepared from control and
low-Mg++ treated hippocampal neuronal cultures at different time intervals post-treatment
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and blotted onto nitrocellulose for immunostaining. Induction of the "epileptic" condition
in these neuronal cultures resulted in no significant change in GABAA p subunit antibody
staining immediately following low Mg++ treatment (Fig. 8) or 24 hours post-treatment (Fig.
9).
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Figure 1.
Induction of spontaneous recurrent seizures in hippocamapal neuronal
cultures. Intracellular recordings were carried out in whole-cell current-clamp mode on
++
sham and low Mg treated hippocampal neuronal cultures following treatment.
A. Electrophysiological analysis of control neurons revealed "normal" baseline
recordings the with occasional generation of spontaneously occurring action potentials.
++
B. Intracellular recording from an "epileptic" neuron after low Mg treatment exhibiting
4 separate seizure discharges. Expansion of one of the seizure bursts displays the
presence of individual PDSs. Further expansion of a 10 sec interval reveals the
complexity of the individual PDSs which display a distinct beginning and termination
with a spike frequency of approximately 17 Hz.
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Figure 2.

Photomicrographs of hippocampal neuronal cultures were obtained from the
same field at different intervals during the treatment protocol. A, Pre-treatment. B, 24 hours
post-low Mg++ . C, Three days post-low Mg++ . (Scale Bar = 100 µm).
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Figure 3.
Northern blots were probed with selective cDNAs constructed to GABAA
receptor subunits, and stringency conditions were determined for specific hybridization
analysis. Poly (A)+ hippocarnpal RNA Northerns were employed for GABAA al, a2,
and a5 cDNA hybridizaiton. Total RNA Northerns were used for GABAA p2 and y2
cDNA hybridization analysis. Numbers denote the size in kilobases (Kb) of detected
mRNA transcripts.
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Figure 4.
Poly-(A) + RNA slot hybridization analysis of GABAA receptor subunit
expression in hippocampal neuronal cultures 24 hours following induction of
spontaneous recurrent seizure activity. Data are expressed as the mean± SEM. *, p �
0.05, Student's t-test.
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Figure 5.

Poly-(A)+ RNA slot hybridization analysis ofGABAA receptor subunit
expression in hippocampal neuronal cultures 3 days following induction of spontaneous
recurrent seizure activity. Data are expressed as the mean± SEM. * ,p = 0.04, Student's
t-test.
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Quantification of irreversible photoaffinity labelling of [3H]-flunitrazepam
to the approximately 50 kilodalton (kDa) a subunit of the GABAA receptor in membranes
++
isolated from control and low Mg hippocampal cultures 3 days following treatment (see
methods). Data are expressed as the mean± SEM (n = 3, each}. * ,P = 0.00016,
Student's t-test.

Figure 6.
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Figure 7.
Voltage-clamp analysis ofhippocampal cultures treated with missense
(control) and antisense oligonucleotide probes constructed against the GABAA cx2
receptor subunit. A. Representative voltage-clamp recordings of spontaneous inhibitory
postsynaptic currents (IPSCs) from hippocampal cultures following 5 days of treatment
with antisense or missense (1 µM) oligonucleotides. B. Quantification of (IPSC)
amplitude from hippocampal neuronal cultures treated with GABAA cx2 antisense. Data
are expressed as the percent mean± SEM of control (missense) (missense: n = 6,
antisense: n = 5). *,p = 0.00003, Student's t-test.
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Figure 8.

++

Protein blot analysis of homogenates from control and low Mg
hippocampal neuronal cultures immediately following low Mg* treatment. A. Antibody
++
staining of control and low Mg hippocampal neuronal culture protein blots using a
mAB specific for the � subunits of the GABAA receptor (see methods).
B. Quantification of GABAA � subunit antibody staining in control and low Mg*
cultures immediately following treatment. Data are expressed as the mean± SEM (n = 5,
each).
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Figure 9.

Protein blot analysis of homogenates from control and low Mg+-1hippocampal neuronal cultures 24 hours post treatment. A. Antibody staining of control
and low Mg++ hippocampal neuronal culture protein blots using a mAB specific for the p
subunits of the GABAA receptor (see methods). B. Quantification ofGABAA P subunit
++
antibody staining in control and low Mg cultures 24 hours post treatment. Data are
expressed as the mean ± SEM (n = 5, each).
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D.

DISCUSSION:
The data presented demonstrate that long-lasting alterations in GABAA receptor

expression are associated with the enduring enhancement of neuronal excitability that ensues
in the hippocampal neuronal culture model of epilepsy. Treatment of primary hippocampal
neuronal cultures with a Mg++-free media for 3 hours results in the induction of an long-lived
"epileptic" condition reflected by the expression of spontaneous recurrent seizure discharges
for the life of the culture (Fig. 1 ). The seizure phenomena displayed in these neuronal
cultures have been shown to exhibit characteristics similar to what is observed in intact
models of epilepsy, thus underscoring the potential this in vitro model offers towards
understanding the molecular mechanisms that underlie this condition (Sombati and
DeLorenzo, 1995).
Changes in GABAergic inhibitory processes have been shown to occur with seizures
and epilepsy, and can arise at several levels within the inhibitory pathway (Dudek and Spitz,
1997; Kapur et al., 1989; Lothrnan et al., 1991). Researchers have hypothesized that a
selective loss of excitatory innervation onto inhibitory intemeurons contributes to the
underlying mechanisms of epileptogenesis associated with temporal lobe epilepsy (Dudek
and Spitz, 1997). This would suggest that the inhibitory machinery remains intact, and that
preceding mechanisms have been arrested. Suppression of GABAergic inhibitory function
at the postsynaptic membrane has also been intensely studied in different models of seizures
and epilepsy (Buhl et al., 1996; Friedman et al., 1994; Gibbs et al., 1997b; Gibbs et al.,
1997a; Isokawa, 1996; Kapur and Macdonald, 1997; Merlin and Wong, 1993; Rice et al.,
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1996). The findings from these investigations show that lasting alterations in GABAA
receptor function occur with seizures and epilepsy. Elucidation of the molecular mechanisms
which underlie these maladaptive changes in GABAA receptor function would most certainly
bring us closer to a better understanding of epileptogenesis.
The heterogeneity in GABAA receptor function observed throughout the CNS has
been proposed to be the result of diverse receptor subunit combinations (McKernan and
Whiting, 1996). It is believed that this diversity in subunit makeup of GABAA receptors is
essential to the overall maintenance of inhibitory mechanisms in the brain. Several
investigations have demonstrated that the presence of selected subunits are essential for
GABAA receptor sorting and assembly. In a mouse strain that is homozygous for a
chromosomal deletion spanning the GABAA cx5 gene, researchers found a deficit in
formation of a subclass of GABAA receptors with paralleled decreases in P2/3 and y2
immunoreactivity in the hippocampus (Fritschy et al., 1997). Selected GABAA subunits have
been shown to control the cellular localization and sorting of the receptor complex in
polarized cells (Perez-Velazquez and Angelides, 1993). In consideration of these findings,
one could postulate that abnormal expression in receptor subunits could evoke
maladaptations in GABAergic processes, thus resulting in a decrement of inhibitory drive.
We have demonstrated a selective and long-lasting decrease in GABAA ex subunit mRNA
expression in association with the induction of the "epileptic" condition in hippocampal
neuronal cultures (Fig. 4 and 5). These findings are in agreement with published results from
both in vitro (Vick et al., 1996) and in vivo (Rice et al., 1996; Houser et al., 1995) models
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of epilepsy.
The GABAA receptor contains a number of both positive and negative modulatory
sites that are intrinsic to its physiological function (Barnard et al., 1987). The action of
benzodiazepines (BZs) on the GABAA receptor complex is one such allosteric mechanism,
and has been shown to occur through binding to the a; subunit (Burt and Karnatchi, 1991).
Decreased BZ receptor binding has been observed in association with both human epilepsy
(Savic et al., 1988), and in animal models ofseizures and epilepsy (Kapur et al., 1994; Kapur
and Macdonald, 1997). Irreversible saturating benzodiazepine binding to the GABAA
receptor complex is an established method for the quantitation of a; subunit protein levels
(Bowling and DeLorenzo, 1987). We have demonstrated that induction of SRSs in
hippocarnpal neuronal cultures results in a significant decrease in [3HJ-flunitrazeparn binding
to the 50 kDa a; subunit of the GABAA receptor (Fig. 6). These findings are further
substantiated by other work carried out with this model showing a significant and long
lasting decrease in the efficacy of clonazeparn augmentation of GABAA receptor response
in association with the "epileptic" condition evidenced in these hippocarnpal cultures (Gibbs
et al., 1997b ).
Whether decreases in GABAA a; subunit mRNA expression and protein levels are
directly involved in the development of the "epileptic" condition observed in this model, or
rather a result of seizure discharges is unclear. To address this question, we utilized
antisense oligonucleotide technology to selectively suppress GABAA a:2 expression in
hippocarnpal neuronal cultures. We demonstrated a significant decrease in IPSC amplitude
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in hippocampal cultures treated with the GABAA ex2 antisense oligonucleotide (Fig. 7A and
B). In addition, previous data from this laboratory has demonstrated that GABAA ex2
antisense "knock-down" treatment ofhippocampal cultures results in a profound increase of
neuronal excitability (Sombati et al., 1995). This data suggests that a selective suppression
of GABAA ex subunit expression can incur alterations in receptor function resulting in
attenuation of inhibitory response.
It has previously been shown the low Mg++ treatment of hippocampal neuronal
cultures and subsequent induction of SRSs resulted in a significant reduction of GABAA
receptor current density (Gibbs et al., 1997b). Recombinant GABAA receptor studies have
demonstrated that both ex and P subunits confer changes in affinity for GABA binding to the
receptor complex (Levitan et al., 1988; Ymer et al., 1989). To determine if changes in
expression for the P class of receptor subunits are associated with the "epileptic" condition
of this culture model, we carried out protein staining with a GABAA p subunit specific
antisera. No change in protein levels for the p class of the GABA A receptor subunits was
observed in association with the induction of SRSs in hippocampal neuronal cultures ( Fig.
8). This data further suggests that selective changes in GABAA ex subunit expression occur
in association with the altered state of neuronal excitability evidenced in the hippocampal
neuronal culture model ofepilepsy.
Results of this study demonstrate for the first time a direct association between
GABAA receptor subunit expression and induction ofSRS activity in an in vitro hippocampal
culture model of epilepsy. Furthermore, this study demonstrates that selective suppression
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of GABAA ex subunit expression can result in a reduction of GABAergic inhibitory response
in hippocarnpal neuronal cultures. The pathogenesis of epilepsy is very complex and is
believed to involve multiple mechanisms. Our data indicate that long-lasting decreased
GABAA subunit gene expression may underlie mechanisms involved in the emergence and
maintenance of some forms of seizures and epilepsy.

DECREASE IN MULTIFUNCTIONAL Ca++/CALMODULIN-DEPENDENT
PROTEIN KINASE II ACTIVITY IN A HIPPOCAMPAL CELL CULTURE
MODEL OF RECURRENT SPONTANEOUS SEIZURE

A.

INTRODUCTION:
The neuropathological condition of epilepsy, a chronic disease associated with

recurrent seizure discharge, affects approximately 1 % of the population (Hauser and
Hesdorffer, 1990). Seizures occur when there is a loss in the ability of the central nervous
system to regulate neuronal activity resulting in the synchronous and uncontrollable firing
of a population of neurons (Lothman et al., 1991). Although there are a number of
phannacological interventions that successfully manage the seizure episodes associated with
epilepsy, the cellular and molecular mechanisms that underlie these neuropathological
manifestations still remain unclear. A substantial amount of evidence suggests that the
primary mechanisms involved in the elicitation of seizures are due to either a suppression of
inhibitory synaptic transmission or enhancement of excitatory synaptic pathways. Although
changes in these two systems, either independently or in concert with each other, demonstrate
a clear relevance in seizure generation at the functional level, the multitude of the underlying
regulatory pathways involved in sustaining the epileptogenic phenotype are very complex.
The Ca++ ion is a major second messenger in the central nervous system. Increases
69
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in intracellular ca++ concentration have been shown to be involved in regulating a wide range
of cellular events including neurotransmitter release, cell survival, dendritic sprouting, and
learning and memory (Bading et al., 1993). The Ca++ signal is transduced via biochemical
regulation of many intracellular proteins some of which include kinases, phosphatases,
proteases and transcription factors. The Ca++ /calmodulin-dependent kinase II enzyme (CaM
Kinase 11) is a major protein kinase that is highly enriched in the brain, constituting 0.5-1.0%
of total brain protein, and up to 2% of hippocampal protein (Erondu and Kennedy, 1985).
Phosphorylation of a multitude of substrates by CaM kinase II enables its modulation of
many cellular processes including neurotransmitter biosynthesis and release, cytoskeletal
structure, ligand-gated and calcium-dependent ion channels, and transcriptional regulation
(Churn, 1995). Furthermore, activation of CaM kinase II has also been shown to play a role
in forms of learning and memory, such as in the model of long-term potentiation (LTP)
(Soderling, 1993). The findings presented above clearly establish the importance of CaM
kinase II in maintaining normal physiological processes throughout the CNS. Alterations in
activity of this enzyme system would be expected to precipitate pathological consequences.
There appears to be a delicate balance in the role that CaM kinase II plays between
physiological and pathological processes that occur in neuronal cells. A change in activity
of CaM kinase II has been associated with a number of neuropathological models which
include stroke (Churn et al., 1992b), pilocarpine-induced TLE (Kochan et al., 1997), kindling
(Goldenring et al., 1986; Wasterlain and Farber, 1984) status epilepticus (Bronstein et al.,
1988; Churn et al., 1991; Perlin et al., 1992; Wasterlain et al., 1992) and NMDA-dependent
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excitotoxicity(Churn et al., 1995).
An increasing amount of evidence suggests a role for alteration of CaM kinase II
function with seizures and epilepsy. Transgenic mice carrying a null mutation(-/-) for a
CaM kinase II have exhibited significant neuronal hyperexcitability and epileptic seizures
arising from limbic structures (Butler et al., 1995).

Perlin and colleagues (1992)

demonstrated, using the rat SE model of continuous hippocampal stimulation, that expression
of seizure discharges was associated with an inhibition of CaM kinase II activity, and that
there was a direct correlation between intensity of seizure activity and degree of inhibition
of the enzyme. Anderson et al.(1986) have shown that treatment of a rat hippocampal slice
preparation with Mg++-free solution resulted in the expression of spontaneous ictal-like
events which resemble tonic and clonic seizure discharges. Analysis of CaM kinase II in
these slice preparations revealed a significant suppression in enzyme activity associated with
the seizure-like events exhibited in this model(Churn et al., 1991 ). Using the kindling model
of epilepsy, Goldenring et al. (1986) found a suppression of Ca++/calmodulin-dependent
kinase activity in hippocampal membrane preparations isolated from kindled brain. These
findings are further substantiated by work from other laboratories demonstrating a kindling
induced alteration in CaM kinase II function represented by decreases in activity(Wasterlain
and Farber, 1984), irnmunoreactivity (Bronstein et al., 1990), and mRNA expression
(Bronstein et al., 1992). In light of these findings, alterations in activity and expression of
CaM kinase II have been shown to occur in models of seizures and epilepsy, and may
contribute to the underlying mechanisms of the pathophysiology exhibited in these
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conditions.
We employed the hippocarnpal cell culture model of recurrent spontaneous seizure
(Sombati and DeLorenzo, 1995) to study the effect ofepileptogenesis on the activity ofCaM
kinase II in a hippocarnpal neuronal culture network. Treatment ofhippocampal cell cultures
with a Mg++_free media for 3 hours results in the induction of an "epileptic" state as
evidenced by the presence ofspontaneous recurrent seizure (SRS) activity throughout the life
ofthe neuronal culture. Decreasing Ca++ concentration to 0.2 mM or addition of50 µM APV
in the Mg++-free exposure media results in the blockade of the expression of SRSs,
suggesting an NMDA receptor, Ca++-dependent mechanism in the induction of the
epileptogenic state in this model. This hippocampal neuronal culture model ofepilepsy is
a powerful tool for investigating the biochemical, biophysical and molecular mechanisms
that underlie seizures and epilepsy in that it allows for easy manipulation and evaluation of
the culture environment.

B.

METHODS:

Primary Hippocampal Neuronal Cultures:

Primary hippocampal cultures were prepared by a modification of the method of
Banker and Cowan (1979) as described by Sombati et al. (1991). Briefly, hippocampi from
2-day postnatal Sprague-Dawley rat pups were dissected out from the brain and prepared for
tissue culture by 0.25% trypsin digestion followed by trituration through a Pasteur pipet.
Triturated cells were counted by cresyl violet blue exclusion analysis using a hemocytometer,
and 2 x 1 O' cells were plated on a 35 mm dish previously coated with growth factor reduced
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MATRIGEL® matrix (Collaborative Biochemical, Bedford, MA) to aid in the attachment
of the hippocampal cells. One day following plating, cultures were treated with 5 µM
cytosine arabinoside to inhibit further non-neuronal cellular proliferation. Hippocampal
cultures were maintained in MEM containing N3 supplement media plus 20% conditioned
media. The N3 supplement contained 25 mM HEPES buffer (pH 7.4), 2 mM glutamine, 5
µg!ml Insulin, 100 µg/ml transferrin, l 00 µM putrescine, 30 T]M sodium selenite, 20 TJM

progesterone, 1 mM sodium pyruvate, 0.1% ovalbumin, 20 T]g/ml T3, 40 T]g/ml
corticosterone. Conditioned media was obtained from confluent hippocampal glia beds
plated out at a density of 1.0 x 106 cells/75 cm2 flasks and maintained in MEM containing
10% fetal bovine serum and 2 mM glutamine. Both hippocampal cell cultures and glia beds
were maintained at 37° C under 5% CO2 95% air.
Mg*-free Treatment ofHippocampal Cell Cultures:

After two weeks in culture, maintenance media was replaced with exposure solution
containing (in mM): 145 NaCl, 2.5 KC!, 10 HEPES, ±1 MgC12, 2 CaC12, 10 glucose, .002
glycine, pH 7.3, and osmolarity adjusted to 325m0sm with sucrose. Cells were washed
gently with 3 x 1.5 ml ofexposure solution with ±1 mM MgCl2 and then allowed to incubate
in this solution for 3 hours at 37 ° C under 5% CO2 95% air. In experiments for determining
NMDA receptor-dependency, hippocampal cultures were treated with 25 µM D-APV for 20
min prior to and during Mg++-free exposure. At the end of treatment, cells were washed
gently with 3 x 1.5 ml ofMEM at 37 ° C, and then media was replaced with maintenance feed
and treated cultures were left undisturbed at 37 ° C under 5% CO2 95% air for specified time
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points post-treatment.
CaM Kinase II Assay:
For quantitation ofCaM kinase II activity, hippocampal neurons were washed twice
with recording solution at 37 ° C. The wash solution was rapidly replaced with ice-cold
homogenization buffer containing 100 mM Tris-HCl (pH 7.4), 6 mM ethylenediamine-tetra
acetic acid (EDTA), 6 mM EGTA, 0.3 mM phenylmethylsulphonyl fluoride (PMSF), and the
cells were immediately scraped from the culture dish surface. The cell suspension was
transferred into a glass homogenizer (Kontes, Vineland, NJ), and disrupted with IO strokes
of the homogenizer. Homogenates were normalized for protein using a micro-Bradford
reagent (Bio-Rad, Hercules,CA) and studied for endogenous calcium-dependent protein
phosphorylation. Standard phosphorylation reaction solutions contained 10-12 µg protein,
10 mM MgCl,, 0.2 mM EDTA, 7 µMy- ["P] ATP (10 ci/mMol, DuPont-NEN, Boston,
MA), 10 mM Tris-HCI (pH 7.4), ±5 µM CaCl, and± I µg calmodulin. Standard reactions
were performed in a shaking water bath at 30 ° C. Reactions were initiated by the addition
of calcium, continued for 1 minute, and terminated by the addition of 5% SDS STOP
solution. Proteins were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE)
and protein bands were visualized by silver-stain as described previously (Churn et al.,
1992a). Stained gels were dried and exposed to x-ray film (XRP-1, Kodak, Rochester, NY)
for autoradiography. Autoradiographs were scanned using HP scanJet 4C/T high resolution
scanner (Hewlett Packard, Boise, ID). Computer-assisted densitometry was utilized to
quantitate intensities ofthe a; (50 kDa) and p (60 kDA) subunits ofCaM kinase II (Mocha0,

75
Jandel Corp., San Rafael, CA).
Phosphocellulose Assay of CaM kinase II Phosphorylation of Syntide II:

Substrate phosphorylation was performed by the modification of a previously
established procedure (Hashimoto and Soderling, 1987). For kinase activity, standard
phosphorylation reactions were performed as described above, except that 60 µM Syntide
II (Sigma Chemical Co., St. Louis, MO) was included in the mixture. This concentration of
Syntide II has been demonstrated to provide maximal phosphate incorporation under
standard conditions (Churn et al., 1995). The phosphorylation reactions were initiated by the
addition of Ca2• , allowed to continue for I min and stopped by the addition of 20 µM
EGTA. For Syntide II phosphorylation time course analysis and evaluation of phosphatase
inhibition, standard reactions were carried out with ± 0.62 µM okadaic acid (phosphatase
inhibitor) and reactions were run for 30s, 60s, 2, I 0, and 20 min before stopping with 20 µM
EGTA. For both standard and time course phosphorylation analysis, 20 µl of the stopped
reaction solution was immediately blotted onto phosphocellulose filter paper, P-81
(Whatman, Maidstone England). Each reaction was measured in triplicate. Blotted P-81
filters were then washed 3 times in 50 mM phosphoric acid to remove unincorporated
phosphate, rinsed with acetone and allowed to air dry. Filters were placed in CytoScint™
scintillation fluid (Fischer Scientific, Fair Lawn, NJ) and incorporation of radioactive
phosphate was measured using a Beckman LS 6500 scintillation counter (Beckman
Instruments Inc., Fullerton, CA).
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ex and P-CaM kinase II Immunoreactivity:
Four to six micrograms of balanced proteins were blotted onto Trans-Blot®
nitrocellulose membrane (Bio-Rad, Hercules,CA) Wlder vacuum filtration using a PR 600
slot blot apparatus (Hoefer Scientific Instruments, San Francisco, CA). Antibody blot
analysis was carried out using a Vectastain® ABC alkaline phosphatase staining kit (Vector
Laboratories, Burlingame, CA). Briefly, protein blots were incubated overnight at 4 °c on
a rotary shaker in a PBS-blocking solution containing: 5.0% dry milk (w/v), 0.05% TWEEN20 and 0.01 % anti-foam. Blots were then incubated in PBS-blocking solution containing a
primary antibody specific for either cx-CaM kinase II (mouse monoclonal IgG, clone 6G9:
BioMol, Plymouth Meeting, PA) or P-CaM kinase II (monoclonal IgG-3, clone 1C3-3D6 )
for 1 hour on rotary shaker at room temperature. Unbound antibody was removed by 3
washes in PBS-blocking solution. Blots were then incubated with a biotinylated secondary
antibody in PBS-blocking solution for 30 min at room temperature. Excess secondary
antibody was removed by 3 washes with PBS. Labeled proteins were reacted with a
peroxidase substrate solution and allowed to develop. The staining reaction was stopped by
washing in several changes of dH20. Developed membranes were allowed to air dry,
digitized using a HP ScanJet 4C!T high resolution scanner (Hewlett Packard, Boise, ID) and
intensity measurements were obtained using a computer-assisted densitometer (Mocha0,
Jandel Corp., San Rafael, CA).
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C.

RESULTS:

Whole-cell patch-clamp analysis was carried out on low Mg++ and sham treated
hippocampal cell cultures at selected time intervals following the treatment protocol.
Electrophysiological analysis of control pyramidal neurons revealed normal activity
exhibited by the presence of spontaneous excitatory postsynaptic potentials (EPSPs), and the
generation of occasional action potentials (Fig. IA). Following low Mg++ -treatment,
hippocampal cultures displayed an enduring "epileptic" alteration evidenced by spontaneous
recurrent seizure bursts that have previously been shown to range in duration from 20 sec to
2 min with a resting membrane potential of neurons ranging between -50 to -65 mV (Sombati
and DeLorenzo, 1995). Further expansion of one of the "epileptic" bursts reveals the
presence of individual PDSs. Even further expansion reveals the complexity of the
individual PDSs with a spike frequency discharge of approximately 17 Hz. The expression
of this hyperexcitable state is a permanent alteration in these neuronal cultures in that the
SRS activity has been shown to persists for the life of the culture (Sombati and DeLorenzo,
1995).
To determine the effect of low Mg++ exposure on hippocampal cell culture
morphology, photomicrographs were obtained before and after treatment of cultures with
Mg++-free media. Prior to treatment with Mg++-free media, hippocampal neuron morphology
was characterized by defined shaped somata with basal and apical dendritic fields extending
outward; these characteristics fit the criteria for established models of hippocampal cell
culture (Banker and Cowan, 1979). No obvious changes in cellular morphology were noted
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in hippocampal cultures at different time points following treatment with low Mg++-exposure
when analyzed at the light microscopic level (Fig. 2). No changes in neuronal density were
observed following the Mt•-free treatment. These findings demonstrated that no prominent
changes in neuronal morphology or density occur as a result of low Mg++ -exposure and
subsequent induction of SRSs.
To determine ifmodifications in substrate phosphorylation by CaM kinase II activity
were associated with the SRSs observed in this model, CaM kinase II-dependent
phosphorylation of exogenously added synthetic peptide (Syntide II) was evaluated using
established procedures (Churn et al., 1995) modified from (Hashimoto and Soderling, 1987).
At different time intervals following the treatment regimen, homogenates were prepared from
"epileptic" and control hippocampal neuronal cultures and proteins were processed and
normalized for kinase assays. One day following induction of SRSs, a significant decrease
in substrate phosphorylation of20.7±5.7% (p = 0.02, n = 5) was observed (Fig. l 0). At five
days post induction of SRSs, a significant decrease of 18.9±8.4% ( p = 0.04, n = 5) was
found in substrate phosphorylation from low-Mg++ treated hippocampal neuronal cultures
(Fig. 11). Immediately following treatment (acute time point), CaM kinase II-dependent
substrate phosphorylation was significantly decreased by 18.8±4.0% ( p = 0.006, n = 9)
relative to sham controls (Fig. 12). These results demonstrate long-lasting reduction in CaM
kinase II-dependent substrate phosphorylation in association with the induction of SRSs in
hippocampal neuronal cultures.
To further characterize CaM kinase II activity, endogenous phosphorylation analysis
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was carried out under conditions for maximal CaM kinase II activity. Homogenates were
prepared from control and low-Mg++ hippocampal cultures one day following treatment.
Standard phosphorylation reactions were conducted, resolved on SDS-P AGE gel
electrophoresis, and incorporation of [32P) into the a (50 kDa) and P (60 kDa) subunits of
CaM kinase II was analyzed using standard procedures (Churn et al., 1995). Induction of
SRSs in hippocampal neuronal cultures resulted in a dramatic reduction of phosphate
incorporation into the a (50 kDa) and

P (60 kDa) subunits of CaM kinase II (Fig.

13).

Autoradiographic analysis and quantitation revealed a significant decrease in CaM kinase II
dependent [ 32P) incorporation of26.7±5.0% (p =0.004, n = 5) and 19.0±5.7% (p =0.012,
n = 5) into the a (50 kDa) and P (60 kDa) subunits ofCaM kinase II respectively (Fig. 14).
This data demonstrates that a decrease in CaM kinase II-dependent endogenous
phosphorylation is associated with the "epileptic" condition evidenced in low Mg++ treated
hippocampal cultures.
The induction ofSRSs exhibited in this in vitro neuronal culture model ofepilepsy
has been shown to be an NMDA receptor, ca++-dependent mechanism (Sombati and
DeLorenzo, 1995). To determine ifthe decrease in activity of CaM kinase II is dependent
on induction ofthe SRS activity in this model, we carried out kinase assays on homogenate
preparations obtained from low Mg++ treated hippocampal cultures with ± 25 µM D-APV
(NMDA receptor antagonist). Neuronal Cultures were harvested immediately following the
3 hour treatment regimen. Addition ofD-APV resulted in total blockade ofthe low Mg++
induced reduction in CaM kinase II-dependent substrate phosphorylation when compared to
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controls and low Mg++ alone preparations (Fig. 12). This finding demonstrates a direct
correlation between the induction of the "epileptic" condition and decrease in activity of
CaM kinase II observed in the hippocampal neuronal culture model of epilepsy.
The decrease in [32P] incorporation into the exogenous Syntide II substrate or the a
(50 kDa) and

p (60 kDa) subunits of CaM kinase II could be attributed to other ca++

dependent mechanisms occurring in this model. Induction of selected phosphatases would
reflect a decrease in phosphate incorporation as observed above. To address this question,
we carried out a Syntide II phosphorylation reaction time course± 0.62 µM okadaic acid
(phosphatase inhibitor) using low Mg++ and control hippocampal culture homogenates
isolated 24 hours post-treatment. Addition of okadaic acid to the phosphorylation reactions
did not block the reduction in CaM kinase II-dependent substrate phosphorylation observed
in low Mg++ treated hippocampal cultures (Fig. 15). Since standard kinase-dependent
substrate phosphorylation reactions are 60 sec in duration, quadruplicate reactions were run
at this time point, and values were plotted as a percent of control (Fig. 16). This data
indicates that induced phosphatase activity is not a contributing factor to the reduction in
phosphate incorporation observed in "epileptic" hippocampal cultures.
Several different modifications of the CaM kinase II enzyme pathway could account
for the decrease in activity observed with low Mg++ treated hippocampal neuronal cultures.
To assess if alterations in protein levels for the a and

p subunits of CaM kinase II were

associated with the observed decrease in enzyme activity, immunoreactivity for both a and
P-CaM kinase II was measured at specified times post Mg++ -free exposure using protein slot
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blot analysis with specific antibodies previously characterized by Western blot techniques
used in our laboratory (Chum et al., 1995). Immediately following the 3 hour low Mg++
treatment regimen, a significant decrease of 7 .04±2.3% ( p = 0.03, n = 5) in a. subunit
protein levels were observed compared to control (Fig. 17). No significant changes were
seen in p subunit imrnunoreactivity at this time point (Fig. 18). One day following Mg++-free
treatment resulted in a significant decrease of 13.1±1.7% (p = 0.004, n = 5) and 12.7±0.9%
(p = 0.008, n = 5) in a. and P-CaM kinase II imrnunoreactivity respectively (Fig. 19 and 20).
These results suggest that modest but significant reductions in CaM kinase II
imrnunoreactivity are associated with induction of SRSs in hippocampal neuronal cultures.
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Seizure-induced inhibition of kinase-dependent substrate phosphorylation
++
of Syntide II in neuronal culture homogenates isolated 24 hours post-low Mg treatment.
Data are expressed as the mean± SEM of control (n = 5). * ,p � 0.02, Student's t-test.

Figure 10.
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Figure 11.
Seizure-induced inhibition of kinase-dependent substrate phosphorylation
of Syntide II in neuronal culture cytosolic fraction isolated 5 days post-low Mg++
treatment. Data are expressed as the mean± SEM of control (n = 5). *, p � 0.04,
Student's t-test.
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Figure 12.

++

Effect of NMDA receptor blockade during low Mg treatment on
seizure-induced inhibition of kinase-dependent substrate phosphorylation ofSyntide II in
neuronal culture homogenates isolated immediately following the treatment protocol.
++
Hippocampal cultures were low Mg treated with±25 µM D-APV (NMDA receptor
++
antagonist). Data are expressed as the mean± SEM (control: n = 9, low Mg : n = 9, low
++
Mg + APV: n = 5). *,p = 0.009, one-way ANOVA.
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Figure 13.
Effect of seizure-induction on endogenous CaM kinase II activity in
++
hippocampal neurons 24 hours post-low Mg treatment. Protein stain and
autoradiograph from a representative SOS-PAGE gel of control and "epileptic"
hippocampal neuronal culture homogenates reacted under standard conditions for CaM
kinase II activity (see methods). Phosphorylation reactions were carried out in the
++
presence (+) or absence (-) ofCa and calmodulin. Lanes I and 2 represent controls
++
reaction. Lanes 3 and 4 represent low Mg treatement. Arrows denote the a (50 kDa)
and p (60 kDa) subunits ofCaM kinase II.

89

Protein Pattern

Autoradiograph

- + - +

- + - +

1

1

60 •
50 •

Ca

2+

2

3

4

2

3

4

90

Figure 14.
Quantification of endogenous CaM kinase II activity from "epileptic"
hippocampal neuronal culture homogenates 24 hours post-low Mg++ treatment.
Phosphorylation of both a (50 kDa) and 13 (60 kDa) subunits ofCaM kianse II was
measured (see Methods). Data are expressed as the mean± SEM (n = 5, each). * ,p::;
0.006, Student's t-test.
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Figure 15.

Reaction duration time course for kinase-dependent substrate
phosphorylation ofSyntide II in homogenates from control( -0-) and low Mg++( -•- )
hippocampal cultures 24 hours post-treatment. Reaction durations were 30 s, 60 s, 2, I 0
and 20 min to determine Syntide II phosphorylation saturation curves.
A. Phosphorylation reactions carried out in the presence(+)or, B. absence(-) of okadaic
acid (phosphatase inhibtor). Data are expressed as counts per minute(CPM) ± SEM of
duplicate quantitations (quadruplicate quantitations were carried out for the 60 s time
point).
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Figure 16.
Kinase-dependent substrate phosphorylation of Syntide II in neuronal
++
culture homogenates isolated 1 day post-low Mg -treatment. Standard one minute
reactions were carried out with± okadaic acid (OA). Quadruplicate reactions were run
++
on pooled samples from sham and low Mg treated groups. Data are expressed as the
mean±SEM.
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Protein blot analysis of homogenates from control and low Mg++
hippocampal neuronal cultures immediately following treatment. A. Antibody staining of
control and low Mg++ hippocampal neuronal culture protein blots using a rnAB specific
for ct-CaM kinase II (see methods). B. Quantification of ct-CaM kinase II antibody
++
staining in control and low Mg cultures immediately following treatment. Data are
expressed as the mean± SEM (n = 5, each). * p s; 0.03, Student's t-test.
Figure 17.
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Figure 18.

++

Protein blot analysis of homogenates from control and low Mg
hippocampal neuronal cultures immediately following treatment. A. Antibody staining of
++
control and low Mg hippocampal neuronal culture protein blots using a mAB specific
for P-CaM kinase II (see methods). B. Quantification of P-CaM kinase II antibody
staining in control and low Mg++ cultures immediately following treatment. Data are
expressed as the mean± SEM (n = 5, each).
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Protein blot analysis of homogenates from control and low Mg++
hippocarnpal neuronal cultures 24 hours post treatment. A. Antibody staining of control
and low Mg++ hippocarnpal neuronal culture protein blots using a rnAB specific for a
CaM kinase II (see methods). B. Quantification of a-CaM kinase II antibody staining in
control and low Mg++ cultures 24 hours post treatment. Data are expressed as the mean±
SEM (n = 5, each). * p :S: 0.004, Student's t-test.
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Protein blot analysis of homogenates from control and low Mg++
Figure 20.
hippocampal neuronal cultures 24 hours post treatment. A. Antibody staining of control
++
and low Mg hippocampal neuronal culture protein blots using a mAB specific for P
CaM kinase II (see methods). B. Quantification of P-CaM kinase II antibody staining in
++
control and low Mg cultures 24 hours post treatment. Data are expressed as the mean±
SEM (n = 5, each). * p � 0.0008, Student's t-test.
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D.

DISCUSSION:
Our results demonstrate a long-lived decrease in CaM kinase II activity in association

with the enduring expression of SRSs in a hippocampal neuronal culture model of epilepsy.
Exposure of hippocampal cultures to a Mg++-free media for 3 hours results in the induction
of an "epileptic" condition evidenced by the long-lasting presence of seizure activity (Fig.
1). No obvious changes in neuronal culture morphology or density were observed in
association with the seizure activity exhibited in this model (Fig. 2). This change in CaM
kinase II function occurs immediately and continues as far out as 5 days following induction
of the "epileptic" condition (Fig. 10-12). Furthermore our findings demonstrate a significant
decrease in endogenous phosphorylation of the ex (50 kDa) and P (60 kDa) subunits of CaM
kinase II in association with the SRS activity in these hippocampal cultures (Fig. 13 and 14).
The epileptiform activity observed in low Mg++ treated hippocampal cultures has been
shown to be associated with rapid increases in intracellular ca++ levels (Sombati and
DeLorenzo, 1995). The entry of Ca++ into neuronal cells acts as a major second messenger
pathway involved in regulating a multitude of cellular processes. Induction of calcium
dependent phosphatases is one such process. Epileptiform-induced activation of these
enzymes could contribute to the reduction of phosphate incorporation observed in substrate
and endogenous phosphorylation analysis from low Mg++ treated hippocampal culture
preparations. We demonstrated that inhibition of phosphatase activity by okadaic acid did
not block the decrease in CaM kinase II activity associated with the "epileptic" condition in
these hippocarnpal neuronal cultures (Fig. 15 and 16). This finding further substantiates that
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the reduction in phosphate incorporation seen with low Mg treatment is due to a decrease
in activity ofCaM kinase II.
Much work in the field ofepilepsy research has centered on the investigation of what
transduction pathways are involved in epileptogenesis. A number ofstudies have implicated
a role for NMDA receptor activation in the development of seizure discharges. Blockade of
NMDA receptor function has been shown to impede the induction of several models of
seizures and epilepsy which include kindling (Sutula et al., 1996) electrically induced status
epilepticus (Young and Dragunow, 1994; Stringer and Lothman, 1992), and low Mg++
induced seizure-like discharges in a hippocampal slice preparation (Anderson et al., 1987).
Induction of SRS activity by low Mg++ treatment of hippocampal neuronal cultures has
previously been shown to be an NMDA receptor, ea++_dependent mechanism (Sombati and
DeLorenzo, 1995). We have demonstrated that the enduring reduction in CaM kinase II
activity observed in this in vitro hippocampal culture model of epilepsy is dependent on
NMDA receptor activation (Fig. 12). This finding gives evidence for a direct correlation
between induction of the "epileptic" condition and decline in activity of CaM kinase II
observed in low Mf• treated hippocampal cultures.
The mechanism(s) involved in the suppression ofCaM kinase II activity in
association with this model of epilepsy may be attributed to modification of the enzyme
system at several different cellular levels of regulation. Decrease in expression of CaM
kinase II mRNA has been shown to occur in a models ofseizures and epilepsy (Bronstein et
al., 1992; Murray et al., 1995). Post-translational modification in CaM kinase II activity has
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also been demonstrated in several models of neurotrauma which include stroke (Churn et al.,
1992a; Churn et al., 1993a), status epilepticus (Bronstein et al., 1988; Perlin et al., 1992;
Wasterlain et al., 1992), and epilepsy (Goldenring et al., 1986; Wasterlain and Farber, 1984).
These observations suggest a decrease in efficacy of CaM kinase II which is not attributable
to proteolytic degradation, but rather the result of a selective modification of the enzyme at
the functional level.
Our data demonstrates a modest but significant decrease in protein levels for both the
a and � subunits of CaM kinase II in association with induction of SRSs in hippocampal
neuronal cultures (Fig. 17-20). No obvious changes in neuronal culture morphology or
density are observed in this model of epilepsy. In contrast to these findings, glutamate
induced excitotoxicity in cultured cortical neurons resulted in a dramatic loss of CaM kinase
II immunoreactivity which preceded the delayed cell death associated with this model (Churn
et al., 1995). In consideration of these observations, one could postulate that the degree of
loss in CaM kinase II protein expression may be directly related to extent of the
neuropathological repercussions, ranging from maladaptive changes in neurophysiology ( i.e.
epilepsy) to excitotoxicity-induced neuronal cell death. Further studies are merited for a
more thorough investigation of altered CaM kinase II protein expression at the cellular level
and how it may play a role in the decrement of enzyme activity observed in this in vitro
model of epilepsy.
The "epileptic" condition displayed in low Mg++ treated hippocampal cultures shares
pathophysiological characteristics observed in intact models of seizures and epilepsy, and
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responds to anticonvulsant drugs commonly used to treat human epilepsy disorders (Sombati
and DeLorenzo, 1995). Thus, this in vitro model of enhanced neuronal excitability lends
itself as an effective tool towards the elucidation of the molecular mechanisms involved in
the propagation and maintenance of seizures and epilepsy. Our results demonstrate a
significant and long-lasting decrease in activity of the multifunctional CaM kinase II enzyme
in association with the induction and maintenance of SRSs in hippocampal cultures and may
contribute to the underlying mechanisms responsible for the pathophysiology observed in this
in vitro model of epilepsy.

Future studies are warranted to investigate the specific

contribution of altered CaM kinase II activity towards the generation of epileptiform
discharges evident in these hippocampal neuronal cultures.

Ca++/CALMODULIN-DEPENDENT PROTEIN KINASE II REGULATION OF
GABAA RECEPTOR FUNCTION IN HIPPOCAMPAL NEURONAL CULTURES:

A.

INTRODUCTION:
The y-amino butyric acid type A (GABA,J receptor is the primary mediator of fast

inhibitory synaptic transmission in the central nervous system. Upon binding of its
endogenous ligand GABA, the receptor channel gates the influx of the chloride anion
inducing a hyperpolarized state culminating in inhibition of excitatory synaptic transmission.
The GABAA receptor channel is a member of the ligand-gated ion channel superfamily which
maintain several criteria for receptor subunit structure. These include the presence of four
highly conserved transmembrane spanning regions, a large NH2-terminal extracellular
domain containing N-linked glycosylation sites and cysteine loops important in binding of
GABA and other ligands to the receptor channel, a large intracellular loop between
transmembrane regions 3 and 4, and pentameric in structure (Barnard et al., 1987). To date,
13 different GABAA receptor subunits have been isolated and cloned which include a:1_., p,_3,
y 1•3, and one 6. The regional differences in expression patterns for the GABAA receptor
subunits underscore the functional heterogeneity observed with this receptor channel
throughout the CNS (McKeman and Whiting, 1996).
108
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All of the GABAA receptor subunits contain at least one consensus site for kinase
dependent protein phosphorylation within the intracellular loop. This is believed to be one
of the underlying mechanisms involved in the functional heterogeneity observed with this
receptor complex throughout the CNS (Bureau and Laschet, 1995; Sigel, 1995).
Phosphorylation-dependent regulation of GABAA receptor function by different transduction
pathways has been demonstrated in a number of studies. Transduction systems involved
have been shown to include NMDA receptor activation (Chen and Wong, 1994; Stelzer and
Shi, 1994), nitric oxide production (Robello et al., 1996), protein kinase G (Leidenheimer,
1996), protein kinase A (Feigenspan and Bormann, 1994), protein kinase C (Krishek et al.,
1994; Sigel et al., 1991) and ca++/calmodulin-dependent protein kinase II (Kano et al., 1996;
McDonald and Moss, 1994; Wang et al., 1995). A role for protein phosphatases in the
regulation of GABAA receptor response has also been demonstrated (Martina et al., 1996).
Regulation of the GABAA receptor by phosphorylation-dependent mechanisms can result in
either enhancement or suppression of channel function depending upon which transduction
pathway is mediating the effect and in what brain region it is occurring.
The Ca++ ion acts as a major second messenger in the central nervous system.
Changes in intracellular Ca++ concentration have been shown to be involved in regulating a
wide range of cellular events including neurotransmitter release, dendritic sprouting,
transcriptional control and learning and memory (Ghosh and Greenberg, 1995). Calcium
produces its action by the biochemical modulation of a multitude of intracellular proteins
some of which include kinases, phosphatases, proteases and transcription factors. One such
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protein is Ca /calmodulin-dependent kinase II (CaM kinase II), a multifunctional enzyme
system that is highly enriched in the CNS. Activation of CaM kinase II has been implicated
in mediating a number of cellular processes some of which include neurotransmitter
biosynthesis and release, cytoskeletal structure, regulation of receptor-gated and voltage
dependent ion channels, and transcriptional control (Bronstein et al., 1993).
Recent findings have demonstrated that CaM kinase II acts to positively modulate
GABAA receptor response. Wang et al. (1995) found that intracellular application of an
active, Ca++-independent (autothiophosphorylated) form of a CaM kinase II resulted in
enhancement of GABAA receptor response in both rat spinal dorsal horn and CA I
hippocampal neurons. This augmentation of GABAA response was reflected by an increase
in both current amplitude and muscimol sensitivity of the receptor channel. In addition, they
demonstrated that application of calyculin A (phosphatase inhibitor) also resulted in
increased GABAA receptor function in these neuronal preparations, suggesting a
phosphorylation-dependent mechanism. A long-lasting ca++-dependent potentiation of
GABA-mediated inhibitory synaptic currents has been demonstrated in cerebellar Purkinje
neurons (Kano, 1994). Inhibition of CaM kinase II with either selective kinase inhibitors
(staurosporin or calmodulin-binding domain) or specific CaM kinase II inhibitors
(calmidazolium or KN62) resulted in blockade of the Ca++_dependent "rebound potentiation"
of GABA-mediated inhibition observed in cerebellar slices (Kano et al., 1996). Churn and
DeLorenzo (1996) have shown that addition of purified rat brain CaM kinase II to a synaptic
plasma membrane preparation significantly increased [3H]-muscimol binding and that
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inhibition of CaM kinase II by selective agents blocked this effect. In light of these findings,
it can be inferred that CaM kinase II acts to positively modulate GABAA receptor response
in these neuronal preparations.
In the present study, we set out to investigate the role ofCaM kinase II in regulating
GABAA receptor function in primary hippocampal neuronal cultures. We used several
experimental approaches to suppress the activity of the CaM kinase II enzyme system in
these cell cultures and then studied GABAA receptor function using whole-cell patch-clamp
analysis. The results indicate that inhibition CaM kinase II results in decreased GABAA
receptor function in hippocampal neuronal cultures.

B.

METHODS:

Primary Hippocampal Neuronal Cultures:
Primary hippocampal cultures were prepared by a modification of the method of
Banker and Cowan (1979) as described by Sombati et al. (1991). Briefly, hippocampi from
2-day postnatal Sprague-Dawley rat pups were dissected out from the brain and prepared for
tissue culture by 0.25% trypsin digestion followed by trituration through a Pasteur pipet.
Triturated cells were then counted by cresyl violet blue exclusion analysis using a
hemocytometer, and 2 x 105 cells were plated on a 35 mm dish previously coated with
growth factor reduced MATRIGEL® matrix (Collaborative Biochemical, Bedford, MA) to
aid in the attachment of the hippocampal cells. One day following plating, cultures were
treated with 5 µM cytosine arabinoside to inhibit further non-neuronal cellular proliferation.
Hippocampal cultures were maintained in MEM containing N3 supplement media plus 20%
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conditioned media. The N3 supplement contained 25 mM HEPES buffer (pH 7.4), 2 mM
glutamine, 5 µg!ml Insulin, 100 µg!ml transferrin, 100 µM putrescine, 30 f]M sodium
selenite, 20 f]M progesterone, 1 mM sodium pyruvate, 0.1 % ovalbumin, 20 f]g/ml T3, 40
t']g/ml corticosterone. Conditioned media was obtained from confluent hippocampal glia
beds plated out at a density of 1.0 x 106 cells/75 cm2 flasks and maintained in MEM
containing 10% fetal bovine serum and 2 mM glutamine. Both hippocampal cell cultures
and glia beds were maintained at 37 ° C under 5% CO2 95% air.
a CaM kinase II Antisense Knockdown Analysis:
Antisense and missense oligonucleotide probes were constructed (Operon
Technologies Inc., Alameda, CA).

For the a CaM kinase II knockdown, an antisense

oligonucleotide complementary to the +1 to +18 nucleotides was constructed with the
following sequence: 5' GGT AGC CAT CCT GGC ACT 3'; missense sequence for a CaM
kinase II was: 5' GGT AGC CAT AAG GGC ACT 3'. Knockdown analysis for a CaM
kinase II involved treating hippocampal cultures for 5 days with 3.0 µM of either antisense
or rnissense oligonucleotides every 24 hours. During the treatment regimen, hippocampal
cultures were maintained in N3 supplement containing 20% conditioned media at 37 ° C under
5% CO2 95% air. At the end of the 5 day treatment protocol, cultures were utilized for
electrophysiological analysis.
Inhibition of CaM Kinase II with KN93:
Hippocampal cultures were treated with either 1 µM KN93 (specific CaM kinase II
inhibitor) or 1 µM KN92 (structurally similar inactive control) for three days during which
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time they were maintained in N 3 supplement containing 20% conditioned media at 37 ° C
under 5% CO2 95% air. At the end of the 3 day treatment protocol, cultures were utilized for
electrophysiological analysis.
Electrophysiological Analysis of IPSC Amplitudes:
For electrophysiological analysis of spontaneous IPSC amplitude, voltage-clamp
recordings were performed using procedures similar to what was utilized by Soltesz et al.
(1995). Briefly, culture medium was changed to recording solution containing (in mM) 1
TDC, 25 APV and 10 CNQX, 145 NaCl, 2.5 KC!, 10 HEPES, 1 MgCl2, 2 CaCl2, 10 glucose,
.002 glycine, pH 7.3 and osmolarity adjusted to 325 mOsm with sucrose. Cultures were then
mounted on the stage ofan inverted microscope (Nikon Diaphot, Japan) and continuously
perfused with recording solution. Patch electrodes with a resistance of2-4 MQ were pulled
on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato, CA) and then fire
polished. The pipet solution contained (in mM) 140 CsCl, 1 MgC12, 10 HEPES, 1.1 EGTA
and adjusted to pH 7.2 with CsOH and 310 mOsm with sucrose. After the patch-clamp was
established on a pyramidal neuron, the membrane potential was clamped at -50 mV and
voltage-clamp recording mode was employed using an Axopatch lD amplifier (Axon
Instruments, Foster City, CA). Data was digitized and transferred to video tape using a PCM
device (Instrutech, Mineola, NY; 18 kHz sampling frequency) and then played back on a DC500 Hz chart recorder (Astro-Med Dash II, Warwick, RI). To evaluate the IPSCs,
digitization analysis and detection of individual rnIPSCs were done using the Strathclyde
Electrophysiology Software WCP Vl.2 (Dagan Corporation, Minneapolis, MN) and IPSC
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amplitudes and frequencies were determined.
C.

RESULTS:

Antisense oligonucleotide DNA probes were used to suppress (knockdown) ex CaM
kinase II in primary hippocampal cultures. ex CaM kinase II antisense treatment of
hippocampal cultures has previously been shown to significantly decrease protein expression
of this enzyme (Sombati et al., 1996). Hippocampal neuronal cultures were treated for 5
days with either ex CaM kinase II antisense or missense (control) probes (3 µM). Intracellular
recordings from pyramidal neurons using whole-cell voltage-clamp mode displayed dramatic
reductions in the amplitude ofIPSCs in neuronal cultures treated with antisense probe (Fig.
21). Quantification of IPSC amplitude by digitization analysis revealed a significant
reduction of 37.5±4.3% (p = 0.002, n = 4) in the antisense-treated group as compared to
missense controls (Fig. 22). Previous work has demonstrated that antisense "knock-down"
of ex CaM kinase II in these hippocampal cultures results in a state of profound neuronal
hype rexcitability (Sombati et al., 1995). Thus, these findings strongly suggest a role for the
regulation ofGABAA receptor function by CaM kinase II in hippocampal neuronal cultures.
The suppression ofits activity results in a loss of GABAergic function and an increase in
neuronal excitability.
To further investigate the association between regulation GABAA receptor function
and the CaM kinase II transduction pathway, hippocampal cultures were treated with either
1.0 µM KN93 (specific inhibitor ofCaM kinase II) or l.O µM KN92 (chemically similar
inactive agent) for three days, and GABAA receptor function was analyzed.
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Electrophysiological analysis using whole-cell voltage-clamp mode revealed that KN93
treatment resulted in a significant decrease of21.5±3.3% (p ,5; 0.0001, KN93: n = 16, KN92:
n = 11) in IPSC amplitude as compared to KN92 treated control cultures (Fig. 23). These
results further substantiate the involvement ofCaM kinase II in mediating GABAA receptor
response in these hippocampal culture preparations.
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Figure 21.

Voltage-clamp analysis ofhippocampal cultures treated with missense
(control) and antisense oligonucleotide probes constructed against a CaM kinase II.
Representative voltage-clamp recordings ofspontaneous inhibitory postsynaptic currents
(IPSCs) from hippocampal cultures following 5 days oftreatment with A. missense or
B. antisense oligonucleotide probes.
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Figure 22.

Quantification of spontaneous inhibitory postsynaptic current (IPSCs)
amplitudes from hippocampal neuronal cultures after 5 days of treatment with antisense
or missense (3 µM) oligonucleotide probes complementary to a CaM kinase II . Data are
expressed as the mean± SEM of control (missense) (missense: n = 4, antisense: n = 4).
*,p = 0.001, Student's t-test.
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Figure 23.
Quantification of spontaneous inhibitory postsynaptic current (IPSCs)
amplitudes from hippocampal neuronal cultures after 3 days of treatment with the
specific CaM kinase II inhibitor KN93 (1 µM). Data are expressed as the mean± SEM
of control (control: n = 11, KN93: n = 16). *,p = 0.0001, Student's t-test.
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D.

DISCUSSION:
This investigation demonstrates that experimental suppression of CaM kinase ll

activity results in a significant decrease of GABAA receptor function in primary hippocampal
neuronal cultures. Antisense oligonucleotide knockdown of a CaM kinase ll subunit
expression in hippocampal neuronal cultures results in a significant reduction of spontaneous
inhibitory postsynaptic current (IPSC) amplitude. Furthermore, treatment of hippocampal
neuronal cultures with the specific CaM kinase II inhibitor KN93 also results in a significant
attenuation oflPSC amplitude. This data provides direct evidence that the CaM kinase II
transduction pathway acts to regulate GABAA receptor function at the postsynaptic
membrane in hippocampal neuronal cultures.
The mechanism(s) by which inhibition of the CaM kinase II transduction
pathway acts to attenuate GABAergic inhibitory function in hippocampal neuronal cultures
is unclear. CaM kinase II is a multifunctional enzyme system that has been implicated in
mediating many cellular processes through transcriptional, translational and post
translational regulatory mechanisms (Churn, 1995).

Phosphorylation of selective

transcription factors such as the serum response factor (SRF), ca••-response element (CaRE)
and the cAMP response element binding protein (CREB) by CaM kinase II has been
demonstrated and implicates a role for CaM kinase II in transcriptional control (Ghosh and
Greenberg, 1995; Miranti et al., 1995). One could postulate that alterations in the CaM
kinase II transduction pathway evokes the expression of a maladaptive phenotype. Aberrant
changes in neuronal plasticity could result in pathophysiological consequences contributing
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to a state of abnormal synaptic transmission. To date, little is known about what specific role
CaM kinase 11 has in controlling long-term expression of neuronal genes.

More

investigations are merited to determine the involvement of CaM kinase II at this level of
cellular regulation.
Post-translational modification of GABAA receptor function by phosphorylation
dependent mechanisms has been well established (Bureau and Laschet, 1995). Kinase
dependent phosphorylation can act to either suppress or enhance GABAA receptor response
contingent upon which transduction pathway is involved (Chen and Wong, 1994; Feigenspan
and Bormann, 1994; McDonald and Moss, 1994; Sigel, 1995; Valenzuela et al., 1995; Wang
et al., 1995).

The Pl, P2 and y2 GABAA receptor subunits have been shown to contain

consensus sites for CaM kinase II-dependent phosphorylation (McDonald and Moss, 1994).
In a synaptic plasma membrane preparation, addition of purified CaM kinase II acts to
significantly enhance [3H]-muscimol binding (Churn and DeLorenzo, 1996). Rebound
potentiation of GABA-mediated currents in a Purkinje neuronal preparation has been shown
to be both a phosphorylation and CaM Kinase II-dependent phenomenon (Kano et al., 1996).
Intracellular injection of an active form of a CaM kinase II into either acutely isolated rat
spinal dorsal horn neurons or CA 1 hippocampal neurons has been shown to result in a
significant enhancement of GABAA receptor function. In addition, inhibition of phosphatase
1 and 2A with calyculin A also resulted in a dramatic increase in GABAA receptor response
in these neuronal preparations (Wang et al., 1995).
The data presented in this study demonstrates that suppression of CaM kinase II
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results in decreased GABAA receptor function in hippocampal neuronal cultures. Given the
3 to 5 day treatment window utilized in this study to suppress CaM kinase II activity, the
exhibited alterations in GABAA channel function could be attributed to aberrant changes in
cellular regulation at multiple levels. Further investigations are warranted to elucidate the
specific mechanism(s) responsible for CaM kinase II-dependent modulation of GABAergic
inhibitory processes in hippocampal neuronal cultures.

GENERAL DISCUSSION:

The results of this research effort test the central hypothesis and demonstrat that
alterations in GABAA receptor expression and enduring suppression in activity of the
multifunctional ca++/calmodulin-dependent protein kinase II system are associated with the
induction of SRS activity in a hippocampal neuronal culture model of epilepsy. In addition,
we show that experimental suppression of CaM kinase II results in a decrease in GABAA
receptor function in hippocampal neuronal cultures. Epilepsy is a complicated condition that
comprises many etiologies and possible causes. A better understanding of the underlying
mechanisms of epileptogenesis will allow for a more effective development of therapeutic
interventions for the treatment of this condition.
Suppressed GABAergic inhibitory function is thought to be one of the primary
mechanisms which contribute to epileptogenesis. Altered GABAA-dependent inhibitory
processes have been demonstrated in a number of models of seizures and epilepsy (Evans
et al., 1994; Isokawa, 1996; Kamphuis et al., 1992; Kapur and Lothman, 1989; Kapur et al.,
1989; Luhmann et al., 1995; Mangan et al., 1995; Merlin and Wong, 1993). Alterations in
several of the modulatory sites on the GABAA receptor channel have been shown to occur
in models of seizures and epilepsy. These include a decrease in BZ sensitivity (Churn et al.,
1997; Kapur and Macdonald, 1997), a decrease in [3HJ-muscimol binding (Kapur et al.,
125
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1994; Rice et al., 1996) and a change in Zn

sensitivity (Buhl et al., 1996; Kapur and

Macdonald, 1997). The underlying mechanism(s) that accounts for the change in GABAA
receptor function is unclear, but may involve alterations in the expression ofselected receptor
subunits resulting in an abnormal assembly of the receptor channel.
Our data demonstrate that induction of SRS activity in hippocampal neuronal cultures
results in a decrease in expression of GABAA ex2 and ex5 mRNA levels. A concurrent
decrease in BZ binding in hippocampal membrane preparations from low Mg++ treated
cultures indicates a decrease in GABAA ex subunit protein expression associated with the
induction of the "epileptic" condition in this model. Of the GABAA ex subunit class, the ex2
and ex5 are the most abundantly expressed in the hippocampus (Wisden et al., 1992). A
reduction in their expression could impart a substantial decrement in the ex subunit protein
contribution to the GABAA receptor assembly, resulting in an altered function of the channel
complex. Utilizing this in vitro model ofepilepsy, Gibbs et al. (1997b) have demonstrated
that induction of SRS activity in hippocampal cultures was associated with a significant
decrease in both the potency of GABA and sensitivity ofclonazepam augmentation for the
GABAA receptor channel. Our findings of a long-lasting decrease in GABAA ex subunit
expression in this in vitro model of epilepsy occurs in conjunction with a significant decrease
in GABAA receptor function. Other studies have found similar results with GABAA receptor
expression in models of seizures and epilepsy. A chronic model ofpilocarpine-induced TLE
in the rat has been shown to demonstrate significant and long-lived decreases in mRNA
levels for GABAA ex2 and ex5 receptor subunits (Houser et al., 1995; Rice et al., 1996). In
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addition, low Mg++-evoked SRSs in hippocampal entorhinal cortical slices have been shown
to result in a significant decrease in GABAA a2 mRNA expression (Vick et al., 1996). In
light of these findings and the results we have presented thus far, one could postulate that
alterations in GABAA receptor expression may contribute to the decrease in channel function
observed in models of seizures and epilepsy.
Whether the decrease in GABAA a subunit expression is a contributing factor to the
reduction in GABAA receptor function and subsequent generation of epileptiform activity
observed in this model is unclear. Using GABAA a2 antisense oligonucleotide (knock-down)
technology, we demonstrate that suppression of this receptor protein subunit evokes a
reduction in GABAA-dependent inhibitory function. Thus, the selective decrease in GABAA
a subunit expression exhibited in "epileptic" neuronal cultures is capable of incurring a
decrement in GABAA receptor response.
The allosteric properties that each GABAA receptor subunit confers on receptor
channel function have been determined by the use of recombinant receptor studies and
expression systems (Benke et al., 1991; Herb et al., 1992; Levitan et al., 1988; Malherbe et
al., 1990; McKeman and Whiting, 1996; Ymer et al., 1989; Ymer et al., 1990). Earlier work
determined that the presence of one or more of the y subunits were necessary for
benzodiazepine sensitivity of the receptor complex, establishing a minimum assembly
requirement of a.P.Yx for the majority of GABAA receptors throughout the brain (Benke et
al., 1991 ). The contributions of the a subunits have been shown to be essential to the
GABAA receptor complex. They contain the binding site for the BZs and contribute to the
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affinity of GABA binding to the receptor complex (Burt and Kamatchi, 1991). Coexpression of the a5 with �2 and y2 subunits has been demonstrated to produce a receptor
complex with the highest affinity for GABA when compared to other subunit combinations
studied. The a5 subunit confers positive cooperativity of GABA channel gating, a functional
property exhibited by native GABAA receptors (Sigel et al., 1990). Recent findings by
Fritschy and colleagues ( 1997) suggest that the contribution of a GABAA receptor a subunit
is essential for proper receptor formation in vivo. Using a mutant mouse model that lacks
expression of the GABAA a5 receptor subunit due to a homozygous deletion of chromosome
7, they demonstrated that the absence of this subunit prevented the assembly of a subclass
of GABAA receptors in the hippocampal formation, with a subsequent decrease in BZ
binding. In addition, there was a reduction in immunoreactivity for the �2 and y2 subunits
in the hippocampus of these mutant mice. In light of these studies, the decrease in GABAA
a subunit expression we observed in association with SRS activity in hippocampal neuronal
cultures could result in an aberrant channel formation. Such an alteration might cause the
suppression of GABAA receptor function and the subsequent generation of the epileptiform
discharges observed with this model.
Increase in intracellular Ca++ concentration plays an integral role in the transduction
of extracellular signals to multiple regulatory mechanisms within the cell by its action on
many different effector proteins (Baimbridge et al., 1992). Depending on the extent of Ca++
entry into neurons, alterations can occur ranging from potentiation of synaptic transmission
to excitotoxic cell death. Thus, the intricate regulation of Ca++ homeostasis is fundamental
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to neuronal cell function and viability. The induction of SRS activity in hippocampal
neuronal cultures has been shown to be a Ca++-dependent mechanism (Sombati and
DeLorenzo, 1995). In addition, the chronic epileptiform discharges evidenced in low Mg++
treated hippocampal cultures have been shown to be associated with rapid rises in
intracellular ca++ concentrations.

These observations imply that a ca++-dependent

mechanism(s) is responsible for the induction and possibly maintenance of the "epileptic"
condition displayed in low Mg++ treated hippocampal neuronal cultures.
CaM kinase II is a multifunctional enzyme that is highly enriched in the brain and
mediates many cellular processes essential to neuronal function and viability (Bronstein et
al., 1993). Phosphorylation-dependent regulation of substrates by CaM kinase II enables its
control over many cellular functions. These include neurotransmitter biosynthesis and
release, transcription, cytoskeletal structure and regulation of ligand-gated and calcium
dependent ion channels (Churn, 1995). Alterations in the activity of CaM kinase II have
been demonstrated in association with models of neurotrauma. These include NMDA
receptor-dependent excitotoxicity (Churn et al., 1995), stroke (Churn et al., 1992a; Hanson
et al., 1994), pilocarpine-induced TLE (Kochan et al., 1997), kindling (Goldenring et al.,
1986; Wasterlain and Farber, 1984) and status epilepticus (Bronstein et al., 1988; Churn et
al., 1991; Perlin et al., 1992; Wasterlain et al., 1992). In addition, decreases in both CaM
kinase II imrnunoreactivity (Bronstein et al., 1990) and mRNA expression (Bronstein et al.,
1992) have been demonstrated in the kindling model of epilepsy. A transgenic mouse model
carrying a null mutation (-/-) for the a subunit of CaM kinase II has been shown to exhibit
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severe neuronal hyperexcitability and limbic seizure activity (Butler et al., 1995). These
findings suggest that altered function of CaM kinase II may contribute to the underlying
mechanisms of these conditions.
Our data demonstrate a long-lasting decrease in activity of CaM kinase II in
association with the chronic expression of epileptiform activity exhibited in low Mg++
treated hippocampal neuronal cultures. The decrement in enzyme activity is detected
immediately after induction of SRSs and continues for as long as 5 days following low Mg++
treatment. We observed a decrease in CaM kinase II a (50 kDa) and p (60 kDa) subunit
immunoreactivity in association with the "epileptic" condition of these hippocampal
neuronal cultures. These results are in agreement with the findings from other studies
demonstrating a decrease in both activity (Bronstein et al., 1988; Churn et al., 1991; Churn
et al., 1997; Goldenring et al., 1986; Kochan et al., 1997; Perlin et al., 1992; Wasterlain and
Farber, 1984; Wasterlain et al., 1992) and immunoreactivity (Bronstein et al., 1990) of CaM
kinase II in models ofseizures and epilepsy.
The mechanism(s) involved in the observed decrease in activity ofCaM kinase II in
association with SRSs is not clear. Several studies have demonstrated that a post
translational modification ofthe CaM kinase II enzyme occurs in association with models
ofstroke (Churn, 1995; Churn et al., 1993a; Churn et al., 1992a) and seizures (Perlin et al.,
1992; Churn et al., 1991). A unique characteristic of CaM kinase II is its ability to undergo
autophosphorylation, creating an autonomous form of the enzyme which enables it to
continue phosphorylating substrates in a ca++/calmodulin-independent manner. It is believed
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that autophosphorylation of CaM kinase II can result in a number of effects on the
holoenzyme. These include conformational changes, subcellular translocation, substrate
specificity, calmodulin binding, susceptibility to proteolysis and alterations in activity
(Dunkley, 1991).
Our results demonstrate a significant decrease in endogenous Ca++/calmodulin
dependent phosphorylation of the a (50 kDa) and P (60 kDa) subunits ofCaM kinase II in
association with SRS activity in hippocampal neuronal cultures. This inhibition of CaM
kinase II-dependent autophosphorylation could reflect a post-translational modification of
the enzyme. From these results we could postulate that the SRS-associated decrease in the
ability ofCaM kinase II to become autonomous may contribute to possible outcomes. First,
a decrease in enzyme activity demonstrated by suppressed substrate-dependent
phosphorylation and secondly, altered protein stability exhibited by decreased
immunoreactivity for the a and p subunits. Further investigations are warranted to determine
what specific modifications ofthe CaM kinase II enzyme complex contribute to the decrease
in activity observed in this in vitro hippocampal neuronal culture model of epilepsy.
The low Mf+ -induced expression of epileptiforrn activity in hippocampal cultures
has previously been shown to be an NMDA receptor, Ca++_dependent mechanism (Sombati
and DeLorenzo, 1995). Our data demonstrate that the addition of25 µM D-APV (NMDA
receptor antagonist) during low Mg++ exposure results in preserving the activity of CaM
kinase II. This finding shows that the decrease in CaM kinase II activity directly correlates
with the induction of SRS activity exhibited in the hippocampal culture model of epilepsy.
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Recent investigations have revealed that the CaM kinase II transduction pathway acts
to positively modulate GABAA receptor function (Aguayo et al., 1998; Chum and
DeLorenzo, 1996; Kano et al., 1996; Wang et al., 1995). Our results demonstrate a decrease
in both CaM kinase II activity and GABAA receptor expression in the hippocampal neuronal
culture model of epilepsy. These alterations occur in conjunction with a decrease in GABAA
receptor function previously demonstrated in this model (Gibbs et al., 1997b). In view of
these findings, we could speculate that the decrease in function of these two systems could
be directly related. To address this issue, we carried out studies to determine if CaM kinase
II acts to modulate GABAA receptor function in hippocampal neuronal cultures. Our data
demonstrate that suppression ofCaM kinase II activity by treatment with either an antisense
oligonucleotide directed towards a CaM kinase II or the specific inhibitor KN93 results in
a significant decrease in IPSC amplitude. The analysis of the IPSC is indicative of GABAA
receptor function at the postsynaptic membrane. Therefore, these findings show that CaM
kinase II can regulate GABAA receptor function in hippocampal neuronal cultures.
The premise that the observed decrease in both CaM kinase II activity and GABAA
receptor expression and function in this in vitro model of epilepsy are directly related is a
challenging and complex query. Kinase-dependent regulation ofGABAA receptor function
has been well established (Sigel, 1995). Moreover, the CaM kinase II transduction pathway
has been shown to enhance GABAA receptor function (Chum and DeLorenzo, 1996; Kano
et al., 1996; Wang et al., 1995). Although it has been demonstrated that the �l, �2 and y2
subunits of the GABAA receptor channel contain consensus sites for CaM kinase II-
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dependent phosphorylation (McDonald and Moss, 1994), no direct evidence has been shown
to indicate this is a mechanism involved in the regulation of receptor function by this enzyme
pathway. The multifunctional nature of CaM kinase II allows for a myriad of possibilities
for its role in regulating GABAA receptor function, ranging from transcriptional mechanisms
to post-translational modification. Further investigations are required to determine if a direct
relationship between the decrease in CaM kinase II activity and GABAA receptor expression
and function exists in association with the "epileptic" condition of this hippocampal culture
model, and if so, what intracellular pathways are involved in this mechanism.
Epileptogenesis is a complex process. This thesis study demonstrates for the first
time that enduring decreases in GABAA a. receptor subunit expression and activity of CaM
kinase II are associated with the induction of SRS activity in an in vitro model of epilepsy.
These alterations may contribute to the underlying mechanisms responsible for the chronic
epileptiform activity expressed in these neuronal cultures. We also demonstrate that
experimental suppression of CaM kinase II activity in hippocampal cultures results in a
reduction of GABAA receptor function. An increased understanding of the mechanisms
which underlie epilepsy and the seizures associated with it will allow for the development
of more efficacious therapeutic interventions for these conditions.
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